Rebe-rich stevia plant and method for screening same

By identifying and cultivating Stevia plants with specific genetic characteristics and using advanced screening techniques, the challenge of enhancing RebE content is addressed, resulting in Stevia plants with elevated steviol glycoside levels suitable for sweetener production.

WO2024248125A1PCT designated stage expired Publication Date: 2024-12-05SUNTORY HLDG LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/020012
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-31
Filing Date
2024-05-31
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Current understanding of Stevia's genetic information is limited, and there is a need for Stevia plants with enhanced RebE content and methods to produce and screen such plants effectively.

Method used

Development of Stevia plants with specific genetic characteristics, including homozygous or heterozygous alleles at specific positions, and methods for crossing and screening to produce plants with high RebE content and steviol glycoside profiles, involving genetic mutations and PCR-based detection techniques.

Benefits of technology

The approach allows for the production of Stevia plants with significantly higher RebE content and steviol glycoside levels, enabling the creation of high-value sweetener products with improved genetic traits and efficient screening methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JPOXMLDOC01-APPB-T000001
    Figure JPOXMLDOC01-APPB-T000001
  • Figure JPOXMLDOC01-APPB-T000002
    Figure JPOXMLDOC01-APPB-T000002
  • Figure JPOXMLDOC01-APPB-T000003
    Figure JPOXMLDOC01-APPB-T000003
Patent Text Reader

Abstract

The present invention provides: a stevia plant body having at least one of genetic features (1) to (6); a method for producing the stevia plant body; a method for screening for the stevia plant body; an extract from the plant body; and others.
Need to check novelty before this filing date? Find Prior Art

Description

Stevia plant with high RebE content and screening method therefor The present invention relates to a stevia plant with high RebE content, a method for producing the same, and a screening method thereof. Stevia is a perennial plant of the Asteraceae family native to Paraguay in South America. Stevia contains various sweetening components that are several tens to several hundreds of times sweeter than sugar, and these sweetening components are extracted and used as natural sweeteners (Patent Document 1). However, much is still unknown about the genetic information of stevia and what genes are involved in controlling events in the body. WO2018 / 124142 Further elucidation of the genetic information of stevia is required. The present invention provides a stevia plant having useful traits, as well as a method for producing and screening for said plant. In one aspect, the present invention provides the following: [1] A stevia plant having at least one of the following genetic characteristics (1) to (5): (1) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 841 to 842 of SEQ ID NO:1 is AAG. (2) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 953 to 964 of SEQ ID NO:1 is GT. (3) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 1338 to 1341 of SEQ ID NO:1 is AG. (4) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 710 to 711 of SEQ ID NO:2 is TTCCGCCATC. (5) Homozygous or heterozygous for an allele in which the base at the position corresponding to position 824 of SEQ ID NO:2 is A. [2] A stevia plant having the genetic trait (6). (6) Homozygous or heterozygous for an allele in which the base at the position corresponding to position 609 of SEQ ID NO:3 is A. [3] A stevia plant body containing 2.9% or more of RebE per unit mass of dried leaves and having a total content of RebE and stevioside per unit mass of dried leaves of 11.2% or more. [4] [1] A method for producing a stevia plant containing at least one steviol glycoside selected from RebD, RebE, RebN, and stevioside in a greater amount than a control stevia plant not having the genetic characteristics (1) to (5), the method comprising a step of crossing the plant according to [1] with a second stevia plant. [5] A method for producing a stevia plant containing at least one steviol glycoside selected from RebE, stevioside, and TSG in a greater amount than a control stevia plant not having the genetic characteristic (6), the method comprising a step of crossing the plant according to [2] or [3] with a second stevia plant. [6] A dead tissue or cell of a plant body according to any one of [1] to [3], or a plant body produced by the method of [4] or [5]. [7] A plant body according to any one of [1] to [3], a plant body produced by the method of [4] or [5], or an extract of dead tissue or dead cells according to [6]. [8] A method for producing an extract containing steviol glycosides, comprising a step of obtaining an extract from a plant body described in any one of [1] to [3], a plant body produced by the method of [4] or [5], or a dead tissue or dead cell described in [6]. [9] A method for producing a purified steviol glycoside product, comprising a step of purifying steviol glycoside from the extract described in [7].

[0010] [1] to [3], a plant produced by the method of [4] or [5], an extract of dead tissue or dead cells according to [6], or an extract according to [7]; Adding the extract to a food or drink, a sweetener composition, a flavoring, or a pharmaceutical ingredient. A method for producing a food or drink, a sweetener composition, a flavoring, or a pharmaceutical, comprising the steps of:

[0011] An extract of a plant body described in any one of [1] to [3], an extract of a plant body produced by the method of [4] or [5], an extract of dead tissue or dead cells described in [6], or a food, beverage, sweetener composition, flavoring, or pharmaceutical product containing the extract described in [7].

[0012] A method for screening the stevia plant according to [1], comprising the step of detecting the presence of at least one of the following genetic characteristics (1) to (5) from a test stevia plant: (1) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 841 to 842 of SEQ ID NO:1 is AAG. (2) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 953 to 964 of SEQ ID NO:1 is GT. (3) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 1338 to 1341 of SEQ ID NO:1 is AG. (4) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 710 to 711 of SEQ ID NO:2 is TTCCGCCATC. (5) Homozygous or heterozygous for an allele in which the base at the position corresponding to position 824 of SEQ ID NO:2 is A.

[0013] A method for screening the stevia plant according to [2] or [3], comprising a step of detecting the presence of the genetic characteristic of homozygosity or heterozygosity for an allele in which the base at the position corresponding to position 609 of SEQ ID NO:3 is A from a test stevia plant.

[0014] A method for producing the plant according to [1], comprising the step of introducing the following mutation into the genome of a stevia plant: (a) A nonsense mutation or a frameshift mutation at a position 5' to the position corresponding to position 1341 of SEQ ID NO:1. (b) A nonsense mutation or a frameshift mutation at a position 5' to the position corresponding to position 824 of SEQ ID NO:2.

[0015] A method for producing the plant according to [2] or [3], comprising the step of introducing a nonsense mutation or a frameshift mutation into the genome of a stevia plant at a position 5' to the position corresponding to position 609 of SEQ ID NO:3. The present invention makes it possible to obtain stevia plants having useful traits, to provide means for producing such plants, and to provide leaves obtained from such plants, and foods, beverages, and the like containing extracts obtained from the leaves. FIG. 1 is a diagram showing the positions of mutations related to genetic features (1) to (3) in the base sequence of SEQ ID NO: 1 (in the order of genetic features (1), (2), and (3) from the 5' side). The left side of the slash in parentheses is the wild-type sequence, and the right side is the mutant sequence. FIG. 2 is a diagram showing the positions of mutations related to genetic features (4) to (5) in the base sequence of SEQ ID NO: 2 (in the order of genetic features (4) and (5) from the 5' side). The left side of the slash in parentheses is the wild-type sequence, and the right side is the mutant sequence. FIG. 3 is a diagram showing the position of mutation related to genetic feature (6) in the base sequence of SEQ ID NO: 3. The left side of the slash in parentheses is the wild-type sequence, and the right side is the mutant sequence. FIG. 4 is a schematic diagram showing the relative positions of the four UGT76G1 genes in the Stevia genome. The present invention will be described in detail below. The following embodiments are merely examples for explaining the present invention, and are not intended to limit the present invention to such embodiments. The present invention can be embodied in various forms without departing from the gist of the present invention. In addition, all documents cited in this specification, as well as published patent publications, patent publications and other patent documents, are incorporated herein by reference. In addition, this specification includes the contents described in the specification and drawings of the Japanese patent application (Patent Application No. 2023-090513) filed on May 31, 2023, which is the basis for the priority claim of this application. 1. Plant of the present invention 1-1. Stevia plant having at least one of the genetic characteristics (1) to (5) In one aspect, the present invention provides a stevia plant having at least one of the following genetic characteristics (1) to (5) (hereinafter, may be referred to as "plant A of the present invention" or "Stevia plant A of the present invention"). (1) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 841 to 842 of SEQ ID NO:1 is AAG. (2) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 953 to 964 of SEQ ID NO:1 is GT. (3) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 1338 to 1341 of SEQ ID NO:1 is AG. (4) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 710 to 711 of SEQ ID NO:2 is TTCCGCCATC. (5) Homozygous or heterozygous for an allele in which the base at the position corresponding to position 824 of SEQ ID NO:2 is A. Hereinafter, the genetic characteristics (1) to (5) may be collectively referred to as “genetic characteristic A of the present invention.” Stevia is a plant having the scientific name Stevia Rebaudiana Bertoni. In a preferred embodiment, the genetic characteristics (1) to (5) are as follows: (1) Heterozygosity for an allele in which the sequence corresponding to positions 841 to 842 of SEQ ID NO:1 is AAG. (2) Heterozygosity for an allele in which the sequence corresponding to positions 953 to 964 of SEQ ID NO:1 is GT. (3) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 1338 to 1341 of SEQ ID NO:1 is AG. (4) Heterozygosity for an allele in which the sequence corresponding to positions 710 to 711 of SEQ ID NO:2 is TTCCGCCATC. (5) Homozygous or heterozygous for an allele in which the base at the position corresponding to position 824 of SEQ ID NO:2 is A. In the present specification, the term "part / position corresponding to" means, when a sequence identical to a reference sequence (e.g., SEQ ID NOs: 1 to 3, etc.) exists in the mRNA, a part / position in that sequence (e.g., positions 841-842, 953-964, 1338-1341, 710-711, 824, 609, etc.) present in the mRNA, and, when a sequence identical to the reference sequence does not exist in the mRNA, means a part / position in the sequence corresponding to the reference sequence in the mRNA, which corresponds to the part / position in the reference sequence. Whether or not a sequence identical to or corresponding to the reference sequence exists in the mRNA can be determined, for example, by amplifying cDNA obtained from the mRNA of the target stevia plant with primers capable of amplifying the reference sequence by PCR, sequencing the amplified product, and performing alignment analysis between the obtained sequence and the reference sequence. Non-limiting examples of sequences corresponding to the reference sequence include, for example, base sequences having sequence identity of 60% or more, 70% or more, 75% or more, 80% or more, 81% or more, 82% or more, 83% or more, 84% or more, 85% or more, 86% or more, 87% or more, 88% or more, 89% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 98.1% or more, 98.4% or more, 98.7% or more, 99% or more, 99.2% or more, 99.5% or more, or 99.8% or more. The portion / position corresponding to the portion / position in the reference sequence in the sequence corresponding to the reference sequence in the mRNA can be determined by taking into consideration the base sequence before and after the portion / position in the reference sequence. For example, by performing alignment analysis between a reference sequence and a sequence corresponding to the reference sequence in mRNA, a portion / position in the sequence corresponding to the reference sequence in mRNA that corresponds to the portion / position in the reference sequence can be determined. For example, taking the "part corresponding to positions 841-842 of SEQ ID NO: 1" of the genetic feature (1) of the present invention as an example, when the mRNA of a stevia plant has a part consisting of the same nucleotide sequence as SEQ ID NO: 1, the "part corresponding to positions 841-842 of SEQ ID NO: 1" is the 841-842 positions from the 5' side of the part consisting of the same nucleotide sequence as SEQ ID NO: 1 in the mRNA. On the other hand, when the mRNA of a stevia plant has a part consisting of a nucleotide sequence that is not identical to SEQ ID NO: 1 but corresponds to it, the mRNA does not have a part consisting of the same nucleotide sequence as SEQ ID NO: 1, so the "part corresponding to positions 841-842 of SEQ ID NO: 1" does not necessarily correspond to positions 841-842 from the 5' side of the part corresponding to SEQ ID NO: 1. However, by considering the nucleotide sequences around positions 841-842 of SEQ ID NO: 1, the "part corresponding to positions 841-842 of SEQ ID NO: 1" in the mRNA of such a stevia plant can be specified. For example, by performing an alignment analysis between the nucleotide sequence of a portion of the mRNA of a stevia plant corresponding to SEQ ID NO: 1 and the nucleotide sequence of SEQ ID NO: 1, it is possible to identify "the portion of the mRNA of a stevia plant corresponding to positions 841 to 842 of SEQ ID NO: 1." A "portion consisting of a base sequence corresponding to SEQ ID NO:1" means, for example, a portion consisting of a base sequence having sequence identity of 60% or more, 70% or more, 75% or more, 80% or more, 81% or more, 82% or more, 83% or more, 84% or more, 85% or more, 86% or more, 87% or more, 88% or more, 89% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 98.1% or more, 98.4% or more, 98.7% or more, 99% or more, 99.2% or more, 99.5% or more, or 99.8% or more to the base sequence of SEQ ID NO:1. In some embodiments related to the genetic feature (1), the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO: 1" includes a portion of cDNA obtained from the mRNA of a Stevia plant, which can be amplified by PCR using a forward primer (e.g., having the sequence of SEQ ID NO: 4) that hybridizes to a complementary sequence of a portion of positions 1 to 840 from the 5' end of SEQ ID NO: 1 (i.e., from the 5' end of SEQ ID NO: 1 to the nucleotides one nucleotide 5' end side of positions 841 to 842 related to the genetic feature (1)) and a reverse primer (e.g., having the sequence of SEQ ID NO: 5) that hybridizes to a portion of positions 1 to 529 from the 3' end of SEQ ID NO: 1 (i.e., from the 3' end of SEQ ID NO: 1 to the nucleotides one nucleotide 3' end side of positions 841 to 842 related to the genetic feature (1)). In some embodiments related to the genetic feature (2), the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO: 1" includes a portion of cDNA obtained from the mRNA of a Stevia plant, which can be amplified by PCR using a forward primer (e.g., having the sequence of SEQ ID NO: 6) that hybridizes to a complementary sequence of a portion of positions 1 to 952 from the 5' end of SEQ ID NO: 1 (i.e., from the 5' end of SEQ ID NO: 1 to the nucleotides 953 to 964 one nucleotide closer to the 5' end of SEQ ID NO: 1) and a reverse primer (e.g., having the sequence of SEQ ID NO: 7) that hybridizes to a portion of positions 1 to 407 from the 3' end of SEQ ID NO: 1 (i.e., from the 3' end of SEQ ID NO: 1 to the nucleotides 953 to 964 one nucleotide closer to the 3' end of SEQ ID NO: 1) In some embodiments related to the genetic feature (3), the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO: 1" includes a portion of cDNA obtained from the mRNA of a Stevia plant, which can be amplified by PCR using a forward primer (e.g., having the sequence of SEQ ID NO: 8) that hybridizes to a complementary sequence of a portion of positions 1 to 1337 from the 5' end of SEQ ID NO: 1 (i.e., from the 5' end of SEQ ID NO: 1 to the nucleotides one nucleotide 5' end side of positions 1338 to 1341 related to the genetic feature (3)) and a reverse primer (e.g., having the sequence of SEQ ID NO: 9) that hybridizes to a portion of positions 1 to 30 from the 3' end of SEQ ID NO: 1 (i.e., from the 3' end of SEQ ID NO: 1 to the nucleotides one nucleotide 3' end side of positions 1338 to 1341 related to the genetic feature (3)). In some embodiments related to the genetic feature (4), the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO:2" includes a portion of cDNA obtained from the mRNA of a Stevia plant, which can be amplified by PCR using a forward primer (e.g., having the sequence of SEQ ID NO:10) that hybridizes to a complementary sequence of a portion of positions 1 to 709 from the 5' end of SEQ ID NO:2 (i.e., from the 5' end of SEQ ID NO:2 to the nucleotides 710 to 711 one nucleotide closer to the 5' end of SEQ ID NO:2) and a reverse primer (e.g., having the sequence of SEQ ID NO:11) that hybridizes to a portion of positions 1 to 666 from the 3' end of SEQ ID NO:2 (i.e., from the 3' end of SEQ ID NO:2 to the nucleotides 710 to 711 one nucleotide closer to the 3' end of SEQ ID NO:2) In some embodiments related to the genetic feature (5), the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO:2" includes a portion of cDNA obtained from the mRNA of a Stevia plant, which can be amplified by PCR using a forward primer (e.g., having the sequence of SEQ ID NO:10) that hybridizes to a complementary sequence of a portion of positions 1 to 823 from the 5' end of SEQ ID NO:2 (i.e., from the 5' end of SEQ ID NO:2 to the nucleotide one nucleotide 5'-terminal side of position 824 related to the genetic feature (5)) and a reverse primer (e.g., having the sequence of SEQ ID NO:11) that hybridizes to a portion of positions 1 to 553 from the 3' end of SEQ ID NO:2 (i.e., from the 3' end of SEQ ID NO:2 to the nucleotide one nucleotide 3'-terminal side of position 824 related to the genetic feature (5)). In some embodiments, the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO:3" includes a portion of cDNA obtained from the mRNA of a Stevia plant, which can be amplified by PCR using a forward primer (e.g., having the sequence of SEQ ID NO:12) that hybridizes to a complementary sequence of a portion of positions 1 to 608 from the 5' end of SEQ ID NO:3 (i.e., from the 5' end of SEQ ID NO:3 to the nucleotide one nucleotide 5'-terminal side of position 609 related to genetic feature (6)) and a reverse primer (e.g., having the sequence of SEQ ID NO:13) that hybridizes to a portion of positions 1 to 771 from the 3' end of SEQ ID NO:3 (i.e., from the 3' end of SEQ ID NO:3 to the nucleotide one nucleotide 3'-terminal side of position 609 related to genetic feature (6)). In a specific embodiment of the genetic characteristic (1), the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO: 1" includes, for example, a portion of cDNA obtained from the mRNA of a stevia plant, which can be amplified by PCR using a forward primer containing the nucleotide sequence of SEQ ID NO: 4 and a reverse primer containing the nucleotide sequence of SEQ ID NO: 5. In a specific embodiment of the genetic characteristic (2), the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO: 1" includes, for example, a portion of cDNA obtained from the mRNA of a stevia plant, which can be amplified by PCR using a forward primer containing the nucleotide sequence of SEQ ID NO: 6 and a reverse primer containing the nucleotide sequence of SEQ ID NO: 7. In a specific embodiment of the genetic characteristic (3), the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO: 1" includes, for example, a portion of cDNA obtained from the mRNA of a stevia plant, which can be amplified by PCR using a forward primer containing the nucleotide sequence of SEQ ID NO: 8 and a reverse primer containing the nucleotide sequence of SEQ ID NO: 9. In a specific embodiment, the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO:2" includes, for example, a portion of cDNA obtained from the mRNA of a stevia plant that can be amplified by PCR using a forward primer containing the nucleotide sequence of SEQ ID NO:10 and a reverse primer containing the nucleotide sequence of SEQ ID NO:11. In a specific embodiment, the "portion consisting of a nucleotide sequence corresponding to SEQ ID NO: 3" includes, for example, a portion of cDNA obtained from the mRNA of a stevia plant that can be amplified by PCR using a forward primer containing the nucleotide sequence of SEQ ID NO: 12 and a reverse primer containing the nucleotide sequence of SEQ ID NO: 13. In a specific embodiment, the "allele in which the sequence corresponding to positions 841-842 of SEQ ID NO: 1 is AAG" comprises the base sequence of SEQ ID NO: 14-16, 35, 41, 43, or 47. In a specific embodiment, the "allele in which the sequence corresponding to positions 953 to 964 of SEQ ID NO: 1 is GT" comprises the base sequence of SEQ ID NO: 17 to 19, 37, 41, 45, or 47. In a specific embodiment, the "allele in which the sequence corresponding to positions 1338 to 1341 of SEQ ID NO: 1 is AG" comprises the base sequence of SEQ ID NO: 20 to 22, 39, 43, 45, or 47. In a specific embodiment, the "allele in which the sequence corresponding to positions 710-711 of SEQ ID NO:2 is TTCCGCCATC" comprises the base sequence of SEQ ID NO:23-25, 49, or 53. In a specific embodiment, the "allele in which the base at the position corresponding to position 824 of SEQ ID NO:2 is A" includes the base sequence of SEQ ID NO:26 to 28, 51, or 53. Here, a site selected from the group consisting of (1) a portion corresponding to positions 841 to 842 of SEQ ID NO:1 (polymorphic site (1) or mutation site (1) of the present invention), (2) a portion corresponding to positions 953 to 964 of SEQ ID NO:1 (polymorphic site (2) or mutation site (2) of the present invention), (3) a portion corresponding to positions 1338 to 1341 of SEQ ID NO:1 (polymorphic site (3) or mutation site (3) of the present invention), (4) a portion corresponding to positions 710 to 711 of SEQ ID NO:2 (polymorphic site (4) or mutation site (4) of the present invention), and (5) a position corresponding to position 824 of SEQ ID NO:2 (polymorphic site (5) or mutation site (5) of the present invention) may be collectively referred to as "polymorphic site A of the present invention" or "mutation site A of the present invention." In addition, a mutation selected from the group consisting of (1) a mutation from AG to AAG in a portion corresponding to positions 841 to 842 of SEQ ID NO: 1 (mutation (1) of the present invention), (2) a mutation from GGGTCGAACCGT to GT in a portion corresponding to positions 953 to 964 of SEQ ID NO: 1 (mutation (2) of the present invention), (3) a mutation from AGAG to AG in a portion corresponding to positions 1338 to 1341 of SEQ ID NO: 1 (mutation (3) of the present invention), (4) a mutation from TC to TTCCGCCATC in a portion corresponding to positions 710 to 711 of SEQ ID NO: 2 (mutation (4) of the present invention), and (5) a mutation from C to A in a position corresponding to position 824 of SEQ ID NO: 2 (mutation (5) of the present invention) may be collectively referred to as "polymorphism A of the present invention" or "mutation A of the present invention". Figure 1 shows positions 841 to 842, 953 to 964, and 1338 to 1341 of SEQ ID NO: 1, and Figure 2 shows positions 710 to 711 and 824 of SEQ ID NO: 2, respectively. The genetic features of the present invention can be determined by PCR, TaqMan PCR, sequencing, microarray, invader, TILLING, random amplified polymorphic DNA (RAD), restriction fragment length polymorphism (RFLP), PCR-SSCP, amplified fragment length polymorphism (AFLP), simple sequence length polymorphism (SSLP), cleaved amplified polymorphic sequence (CAPS), derived cleaved amplified polymorphic sequence (dCAPS), allele-specific oligonucleotide (ASO), ARMS, denaturing gradient gel electrophoresis (DGGE), chemical cleavage of mismatch (CCM), DOL, MALDI-TOF / MS, TDI, padlock probe, molecular beacon, dynamic allele specific hybridization (DASH), UCAN, ECA, PINPOINT, primer oligo base extension (PROBE), very short extension (VSET), Survivor Detection can be performed by, but is not limited to, methods such as PCR assay, Sniper assay, Luminex assay, GOOD method, LCx method, SNaPshot method, Mass ARRAY method, pyrosequencing method, SNP-IT method, melting curve analysis method, etc. In some embodiments, the plant A of the present invention has any one of the genetic characteristics (1) to (5). In some embodiments, the plant A of the present invention has any two of the genetic characteristics (1) to (5) (e.g., genetic characteristics (1)+(2), (1)+(3), (1)+(4), (1)+(5), (2)+(3), (2)+(4), (2)+(5), (3)+(4), (3)+(5) or (4)+(5)), any three of the genetic characteristics (1)+(2)+(3), (1)+(2)+(4), (1)+(2)+(5 ...2)+(5), (1)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2)+(2) (3)+(4), (1)+(3)+(5), (1)+(4)+(5), (2)+(3)+(4), (2)+(3)+(5), (2)+(4)+(5) or (3)+(4)+(5)), any four (e.g., genetic characteristics (1)+(2)+(3)+(4), (1)+(2)+(3)+(5), (1)+(2)+(4)+(5) or (2)+(3)+(4)+(5)), or all of the genetic characteristics (1) through (5). In a specific embodiment, plant A of the present invention has, among genetic characteristics (1) to (5), genetic characteristic (1) alone, genetic characteristic (3) alone, genetic characteristic (4) alone, a combination of genetic characteristics (1) and (2), a combination of genetic characteristics (1) and (3), a combination of genetic characteristics (3) and (4), or a combination of genetic characteristics (3) and (5). In a preferred embodiment, plant A of the present invention has genetic characteristic (4) or a combination of genetic characteristic (4) and another genetic characteristic (e.g., a combination of genetic characteristics (3) and (4)). In some embodiments, the plant A of the present invention contains at least one steviol glycoside selected from rebaudioside D, E, N, and stevioside in a greater amount than a control stevia plant not having the genetic characteristic of the present invention. Hereinafter, this trait may be referred to as "chemical characteristic A1 of the present invention." In addition, the trait containing more rebaudioside D than the control stevia plant may be referred to as "chemical characteristic A1-1 of the present invention," the trait containing more rebaudioside E than the control stevia plant may be referred to as "chemical characteristic A1-2 of the present invention," the trait containing more rebaudioside N than the control stevia plant may be referred to as "chemical characteristic A1-3 of the present invention," and the trait containing more stevioside than the control stevia plant may be referred to as "chemical characteristic A1-4 of the present invention." "Contains more than a control stevia plant" means, for example, that when grown under the same cultivation conditions, the content of the above-mentioned component (e.g., the content in dried leaves) is greater than that of a control stevia plant, preferably statistically significantly greater. More specifically, for example, when cultivated under the same cultivation conditions, the content of the above components in the dried leaves is more than 1-fold, about 1.1-fold or more, about 1.2-fold or more, about 1.3-fold or more, about 1.4-fold or more, about 1.5-fold or more, about 1.6-fold or more, about 1.7-fold or more, about 1.8-fold or more, about 1.9-fold or more, about 2-fold or more, about 2.1-fold or more, about 2.2-fold or more, about 2.3-fold or more, about 2.4-fold or more, about 2.5-fold or more, about 2.6-fold or more, about 2.7-fold or more, about 2.8-fold or more, about 2.9-fold or more, about 3-fold or more, about 3.1-fold or more, about 3.2-fold or more, about 3.3-fold or more, about 3.4-fold or more, about 3.5-fold or more, about 3.6-fold or more, about 3.7-fold or more than the content in the control stevia plant. , about 3.8 times or more, about 3.9 times or more, about 4 times or more, about 4.1 times or more, about 4.2 times or more, about 4.3 times or more, about 4.4 times or more, about 4.5 times or more, about 4.6 times or more, about 4.7 times or more, about 4.8 times or more, about 4.9 times or more, about 5 times or more, about 6 times or more, about 7 times or more, about 8 times or more, about 9 times or more, about 10 times or more, about 15 times or more, about 20 times or more, about 25 times or more, about 30 times or more, about 35 times or more, about 40 times or more, about 45 times or more, about 50 times or more, about 55 times or more, about 60 times or more, about 65 times or more, about 70 times or more, about 75 times or more, about 80 times or more, about 85 times or more, about 90 times or more, about 95 times or more, or about 100 times or more. Also, for example, when the content of the above-mentioned component in the dried leaves of the population of the plant A of the present invention and the content of the above-mentioned component in the dried leaves of the population of the control Stevia plant are tested by Welch's t-test, the average value of the former is greater than the average value of the latter, and the P value of the two-sided test is less than 0.05, preferably less than 0.01, and particularly preferably less than 0.005. The contents to be compared may be the average values ​​of multiple individuals. In the present specification, the term "dried leaves" refers to fresh leaves of the stevia plant of the present invention that have been dried to reduce the moisture content to 3 to 4% by weight. In the present specification, stevioside may be abbreviated as "ST" and rebaudioside may be abbreviated as "Reb." or "Reb". For example, rebaudioside D may be abbreviated as "Reb.D" or "RebD". In some embodiments, the content of RebD in the dried leaves of the plant A of the present invention is more than 1-fold, about 1.1-fold or more, about 1.2-fold or more, about 1.3-fold or more, about 1.4-fold or more, about 1.5-fold or more, about 1.6-fold or more, about 1.7-fold or more, about 1.8-fold or more, about 1.9-fold or more, about 2-fold or more, about 2.2-fold or more, about 2.4-fold or more, about 2.6-fold or more, about 2.8-fold or more, about 3-fold or more, about 3.2-fold or more, about 3.4-fold or more, about 3.6-fold or more, about 3.8-fold or more, about 4-fold or more, about 4.2-fold or more, about 4.4-fold or more, about 4.6-fold or more, about 4.8-fold or more, about 5-fold or more, about 5.5-fold or more, about 6-fold or more, about 6.5-fold or more, about 7-fold or more, about 7.5-fold or more, or about 8-fold or more of the content of RebD in the control Stevia plant. In some embodiments, the content of RebE in the dried leaves of the plant A of the present invention is more than 1-fold, about 1.5-fold or more, about 2-fold or more, about 3-fold or more, about 4-fold or more, about 5-fold or more, about 6-fold or more, about 7-fold or more, about 8-fold or more, about 9-fold or more, about 10-fold or more, about 12-fold or more, about 14-fold or more, about 16-fold or more, about 18-fold or more, about 20-fold or more, about 25-fold or more, about 30-fold or more, about 35-fold or more, about 40-fold or more, about 45-fold or more, about 50-fold or more, about 55-fold or more, about 60-fold or more, about 65-fold or more, about 70-fold or more, about 75-fold or more, about 80-fold or more, about 85-fold or more, about 90-fold or more, about 95-fold or more, or about 100-fold or more of the content of RebE in the control stevia plant. In some embodiments, the content of RebN in the dried leaves of the plant A of the present invention is more than 1-fold, about 1.1-fold or more, about 1.2-fold or more, about 1.3-fold or more, about 1.4-fold or more, about 1.5-fold or more, about 1.6-fold or more, about 1.7-fold or more, about 1.8-fold or more, about 1.9-fold or more, about 2-fold or more, about 2.2-fold or more, about 2.4-fold or more, about 2.6-fold or more, about 2.8-fold or more, about 3-fold or more, about 3.2-fold or more, about 3.4-fold or more, about 3.6-fold or more, about 3.8-fold or more, about 4-fold or more, about 4.2-fold or more, about 4.4-fold or more, about 4.6-fold or more, about 4.8-fold or more, about 5-fold or more, about 5.5-fold or more, about 6-fold or more, about 6.5-fold or more, about 7-fold or more, about 7.5-fold or more, or about 8-fold or more of the content of RebN in the control Stevia plant. In some embodiments, the content of ST in the dried leaves of the plant A of the present invention is more than 1-fold, about 1.1-fold or more, about 1.2-fold or more, about 1.3-fold or more, about 1.4-fold or more, about 1.5-fold or more, about 1.6-fold or more, about 1.7-fold or more, about 1.8-fold or more, about 1.9-fold or more, about 2-fold or more, about 2.2-fold or more, about 2.4-fold or more, about 2.6-fold or more, about 2.8-fold or more of the content of ST in the dried leaves of the plant A of the present invention. , about 3 times or more, about 3.5 times or more, about 4 times or more, about 4.5 times or more, about 5 times or more, about 5.5 times or more, about 6 times or more, about 6.5 times or more, about 7 times or more, about 7.5 times or more, about 8 times or more, about 8.5 times or more, about 9 times or more, about 9.5 times or more, about 10 times or more, about 10.5 times or more, about 11 times or more, about 11.5 times or more, about 12 times or more, about 12.5 times or more, or about 13 times or more. In some embodiments, plant A of the present invention contains at least one steviol glycoside selected from RebA and RebG in a smaller amount than a control stevia plant not having the genetic characteristic of the present invention. Hereinafter, this trait may be referred to as "chemical characteristic A2 of the present invention." In addition, a trait containing less RebA than a control stevia plant may be referred to as "chemical characteristic A2-1 of the present invention," and a trait containing less RebG than a control stevia plant may be referred to as "chemical characteristic A2-2 of the present invention." "Contains less than the control stevia plant" means, for example, that the content of the above-mentioned component (e.g., the content in the dried leaves) is less than that of the control stevia plant when cultivated under the same cultivation conditions, preferably statistically significantly less. More specifically, for example, when cultivated under the same cultivation conditions, the content of the above-mentioned component in the dried leaves is less than 1 times, about 0.98 times or less, about 0.96 times or less, about 0.94 times or less, about 0.92 times or less, about 0.9 times or less, about 0.88 times or less, about 0.86 times or less, about 0.84 times or less, about 0.82 times or less, about 0.8 times or less, about 0.78 times or less, about 0.76 times or less, about 0.74 times or less, about 0.72 times or less, about 0.7 times or less, about 0.65 times or less, about 0.6 times or less, about 0.55 times or less, about 0.5 times or less, about 0.4 times or less. This means 5 times or less, about 0.4 times or less, about 0.38 times or less, about 0.36 times or less, about 0.35 times or less, about 0.34 times or less, about 0.32 times or less, about 0.3 times or less, about 0.28 times or less, about 0.27 times or less, about 0.26 times or less, about 0.25 times or less, about 0.24 times or less, about 0.22 times or less, about 0.2 times or less, about 0.18 times or less, about 0.16 times or less, about 0.15 times or less, about 0.14 times or less, about 0.12 times or less, about 0.1 times or less, about 0.08 times or less, about 0.06 times or less, about 0.04 times or less, or about 0.02 times or less, etc. Also, for example, when the content of the above-mentioned component in the dried leaves of the population of the plant A of the present invention and the content of the above-mentioned component in the dried leaves of the population of the control Stevia plant are tested by Welch's t-test, the average value of the former is smaller than the average value of the latter, and the P value of the two-sided test is less than 0.05, preferably less than 0.01, and particularly preferably less than 0.005. The contents to be compared may be the average values ​​of multiple individuals. In some embodiments, the content of RebA in the dried leaves of plant A of the present invention is less than 1-fold, about 0.98-fold or less, about 0.96-fold or less, about 0.94-fold or less, about 0.92-fold or less, about 0.9-fold or less, about 0.88-fold or less, about 0.86-fold or less, about 0.84-fold or less, about 0.82-fold or less, about 0.8-fold or less, about 0.78-fold or less, about 0.76-fold or less, about 0.74-fold or less, about 0.72-fold or less, about 0.7-fold or less, about 0.65-fold or less, about 0.6-fold or less, about 0.55-fold or less, about 0.5-fold or less, about 0.45-fold or less, about 0.4-fold or less, about 0.35-fold or less, about 0.3-fold or less, about 0.25-fold or less, about 0.2-fold or less, about 0.15-fold or less, or about 0.1-fold or less of the content of RebA in the control Stevia plant. In some embodiments, the content of RebG in the dried leaves of the plant A of the present invention is less than 1-fold, about 0.95-fold or less, about 0.9-fold or less, about 0.85-fold or less, about 0.8-fold or less, about 0.75-fold or less, about 0.7-fold or less, about 0.65-fold or less, about 0.6-fold or less, about 0.55-fold or less, about 0.5-fold or less, about 0.45-fold or less, about 0.4-fold or less, about 0.38-fold or less, about 0.36-fold or less, about 0.34 times or less, about 0.32 times or less, about 0.3 times or less, about 0.28 times or less, about 0.27 times or less, about 0.26 times or less, about 0.25 times or less, about 0.24 times or less, about 0.22 times or less, about 0.2 times or less, about 0.18 times or less, about 0.16 times or less, about 0.14 times or less, about 0.12 times or less, about 0.1 times or less, about 0.08 times or less, about 0.06 times or less, about 0.04 times or less, or about 0.02 times or less. In some embodiments, plant A of the present invention expresses less of the UGT76G1 family selected from UGT76G1-1 and UGT76G1-4 than a control stevia plant not having the genetic feature of the present invention. Hereinafter, this trait may be referred to as "chemical feature A3 of the present invention." In addition, the trait of expressing less UGT76G1-1 than the control stevia plant may be referred to as "chemical feature A3-1 of the present invention," and the trait of expressing less UGT76G1-4 than the control stevia plant may be referred to as "chemical feature A3-2 of the present invention." "Expressed less than in a control stevia plant" means, for example, that the expression level of the gene (e.g., expression level in dried leaves) is less than that of a control stevia plant when cultivated under the same cultivation conditions, preferably statistically significantly less. More specifically, for example, when cultivated under the same cultivation conditions, the expression level of the gene in dried leaves is less than 1-fold, about 0.95-fold or less, about 0.9-fold or less, about 0.85-fold or less, about 0.8-fold or less, about 0.75-fold or less, about 0.7-fold or less, about 0.65-fold or less, about 0.6-fold or less, about 0.55-fold or less, about 0.5-fold or less, about 0.48-fold or less, about 0.46-fold or less, about 0.45-fold or less, about 0.44-fold or less, about 0.43-fold or less, about 0.42-fold or less, about 0.5-fold or less, about 0.5-fold or less, about 0.5-fold or less, about 0.6-fold or less, about 0.7-fold or less, about 0.8-fold or less, about 0.8-fold or less, about 0.9-fold or less, about 0.9-fold or less, about 0.8 ...7-fold or less, about 0.7-fold or less, about 0.6-fold or less, about 0.5-fold or less, about 0.48-fold or less, about 0.46-fold or less, about 0.45-fold or less, about 0.44-fold or less, This means about 0.41 times or less, about 0.4 times or less, about 0.38 times or less, about 0.36 times or less, about 0.35 times or less, about 0.34 times or less, about 0.33 times or less, about 0.32 times or less, about 0.3 times or less, about 0.28 times or less, about 0.26 times or less, about 0.24 times or less, about 0.22 times or less, about 0.2 times or less, about 0.18 times or less, about 0.16 times or less, about 0.14 times or less, about 0.12 times or less, about 0.1 times or less, about 0.08 times or less, about 0.06 times or less, or about 0.05 times or less, etc. Furthermore, for example, when the expression level of the above gene in dried leaves in a population of plant A of the present invention and the expression level of the above gene in dried leaves in a population of control stevia plants are tested by Welch's t-test, the average value of the former is smaller than the average value of the latter, and the P value of the two-sided test is less than 0.05, preferably less than 0.01, and particularly preferably less than 0.005. In some embodiments, the expression level of UGT76G1-1 in the leaves of plant A of the present invention is less than 1-fold, about 0.95-fold or less, about 0.9-fold or less, about 0.85-fold or less, about 0.8-fold or less, about 0.75-fold or less, about 0.7-fold or less, about 0.65-fold or less, about 0.6-fold or less, about 0.55-fold or less, about 0.5-fold or less, about 0.45-fold or less, about 0.4-fold or less, about 0.38-fold or less, about 0.7-fold or less, about 0.8-fold or less, about 0.9-fold or less, about 0.9-fold or less, about 0.8-fold or less, about 0.7-fold or less, about 0.7-fold or less, about 0.65-fold or less, about 0.6-fold or less, about 0.55-fold or less, about 0.5-fold or less, about 0.45-fold or less, about 0.4-fold or less, about 0.38-fold or less, about 0.7-fold or less, about 0.8-fold or less, about 0.9-fold or less, about 0.9-fold or less, about 0.8-fold or less, about 0.9-fold or less, about 0.8-fold or less, about 0.7-fold or less, about 0.7-fold or less, about 0.65-fold or less, about 0.6-fold or less, about 0.55-fold or less, about 0.5-fold or less, about 0.45-fold or less, about 0.4-fold or less, about 0.38-fold or less, about 0.8-fold or less, about 0.9-fold or less, about 0.9-fold or less, about 0.36 times or less, about 0.35 times or less, about 0.34 times or less, about 0.33 times or less, about 0.32 times or less, about 0.3 times or less, about 0.28 times or less, about 0.26 times or less, about 0.24 times or less, about 0.22 times or less, about 0.2 times or less, about 0.18 times or less, about 0.16 times or less, about 0.14 times or less, about 0.12 times or less, about 0.1 times or less, about 0.08 times or less, about 0.06 times or less, or about 0.05 times or less. In some embodiments, the expression level of UGT76G1-4 in the leaves of plant A of the present invention is less than 1-fold, about 0.95-fold or less, about 0.9-fold or less, about 0.85-fold or less, about 0.8-fold or less, about 0.75-fold or less, about 0.7-fold or less, about 0.65-fold or less, about 0.6-fold or less, about 0.55-fold or less, about 0.5-fold or less, about 0.48-fold or less, about 0.46 times or less, about 0.45 times or less, about 0.44 times or less, about 0.43 times or less, about 0.42 times or less, about 0.41 times or less, about 0.4 times or less, about 0.36 times or less, about 0.32 times or less, about 0.28 times or less, about 0.24 times or less, about 0.2 times or less, about 0.16 times or less, about 0.12 times or less, about 0.08 times or less, about 0.06 times or less, or about 0.05 times or less. Plant A of the present invention may have a combination of two or more of the above chemical characteristics. For example, plant A of the present invention may have chemical characteristics A1, A2, and A3 of the present invention, or at least two of chemical characteristics A1-1 to A1-4, A2-1 to A2-2, and A3-1 to A3-2 (e.g., 2, 3, 4, 5, 6, 7, or 8 of these chemical characteristics). The content of steviol glycosides can be measured by the method described in Ohta et al., J. Appl. Glycosci., Vol. 57, No. 3, 199-209 (2010) or WO2010 / 038911, or the method described in the Examples below. More specifically, the content of steviol glycosides can be measured, for example, by sampling fresh leaves from a Stevia plant and performing LC / MS-MS. The expression level of the UGT76G1 family (e.g., UGT76G1-1 or UGT76G1-4, or a mutant thereof) can be measured by sequencing using NGS or the like described in the Examples below, or any known method for measuring the expression level of a gene, for example, various hybridization methods (e.g., in situ hybridization) using a nucleic acid molecule encoding the UGT76G1 family or a nucleic acid molecule that specifically hybridizes to a unique fragment thereof, Northern blotting, Southern blotting, various PCR methods, immunoprecipitation using a substance that can specifically recognize the UGT76G1 family, such as an antibody, EIA (enzyme immunoassay) (e.g., ELISA (enzyme-linked immunosorbent assay), etc.), RIA (radio immunoassay) (e.g., IRMA (immunoradiometric assay), RAST (radioallergosorbent test), RIST (radioimmunosorbent test), etc.), Western blotting, immunohistochemistry, immunocytochemistry, flow cytometry, MRI, and other methods. The CDS sequences and amino acid sequences of Stevia UGT76G1-1 or UGT76G1-4 or their variants are shown in Table 1. 1-2. Stevia plant with genetic characteristic (6) In another aspect, the present invention provides a stevia plant having genetic characteristic (6) (hereinafter, may be referred to as "plant B of the present invention" or "stevia plant B of the present invention"). (6) Homozygous or heterozygous for an allele in which the base at the position corresponding to position 609 of SEQ ID NO:3 is A. In a specific embodiment, the "allele in which the base at the position corresponding to position 609 of SEQ ID NO:3 is A" includes the base sequence of SEQ ID NO:29 to SEQ ID NO:31 or SEQ ID NO:55. Herein, the position corresponding to position 609 of SEQ ID NO:3 may be referred to as "polymorphic site (6) of the present invention" or "mutation site (6) of the present invention," and the mutation from T to A at position corresponding to position 609 of SEQ ID NO:3 may be referred to as "polymorphism (6) of the present invention" or "mutation (6) of the present invention." Position 609 of SEQ ID NO:3 is shown in Figure 3. Furthermore, "polymorphic site A of the present invention" and "polymorphic site (6) of the present invention" may be collectively referred to as "polymorphic site of the present invention," "mutation site A of the present invention" and "mutation site (6) of the present invention" may be collectively referred to as "mutation site of the present invention," "polymorphism A of the present invention" and "polymorphism (6) of the present invention" may be collectively referred to as "polymorphism of the present invention," and "mutation A of the present invention" and "mutation (6) of the present invention" may be collectively referred to as "mutation of the present invention." In some embodiments, plant B of the present invention contains more RebE, ST and / or TSG than a control stevia plant not having the genetic characteristic of the present invention. (Hereinafter, this trait may be referred to as "chemical characteristic B1 of the present invention.") In addition, a trait containing more RebE than the control stevia plant may be referred to as "chemical characteristic B1-1 of the present invention," a trait containing more ST than the control stevia plant may be referred to as "chemical characteristic B1-2 of the present invention," and a trait containing more TSG than the control stevia plant may be referred to as "chemical characteristic B1-3 of the present invention." As used herein, TSG (total steviol glycosides) refers to a combination of RebA, RebB, RebC, RebD, RebE, RebF, RebG, RebM, RebN and ST. "Contains more than a control stevia plant" means, for example, that the content of the above component (e.g., the content in dried leaves) is greater than that of a control stevia plant when grown under the same cultivation conditions, preferably statistically significantly greater. More specifically, for example, when grown under the same cultivation conditions, the content of the above component in dried leaves is more than 1-fold, about 1.01-fold or more, about 1.02-fold or more, about 1.03-fold or more, about 1.04-fold or more, about 1.05-fold or more, about 1.06-fold or more, about 1.07-fold or more, about 1.08-fold or more, about 1.09-fold or more, about 1.1-fold or more, about 1.2-fold or more, about 1.3-fold or more, about 1.4-fold or more, about 1.5-fold or more, about 1.6-fold or more, about 1.7-fold or more, about 1.8-fold or more, about 1.9-fold or more, about 1.1-fold or more, about 1.2-fold or more, about 1.3-fold or more, about 1.4-fold or more, about 1.5-fold or more, about 1.6-fold or more, about 1.8-fold or more, about 1.9 ...1-fold or more, about 1.2-fold or more, about 1.3-fold or more, about 1.4-fold or more, about 1.5-fold or more, about 1.6-fold or more, about 1.7-fold or more, about 1.8-fold or more, about 1.9-fold or more 5 times or more, approximately 1.6 times or more, approximately 1.7 times or more, approximately 1.8 times or more, approximately 1.9 times or more, approximately 2 times or more, approximately 2.1 times or more, approximately 2.2 times or more, approximately 2.3 times or more, approximately 2.4 times or more, approximately 2.5 times or more, approximately 2.6 More than 2.7 times, About 2.8 times or more, About 2.9 times or more, About 3 times or more, About 3.1 times or more, About 3.2 times or more, About 3.3 times or more, About 3.4 times or more, About 3.5 times or more, About 3.6 times or more, About 3.7 times or more Above, about 3.8x or more, about 3.9x or more, about 4x or more, about 4.5x or more, about 5x or more, about 5.5x or more, about 6x or more, about 6.5x or more, about 7x or more, about 7.5x or more, about 8x or more, about 8.5x or more, about 9x or more, about 9.5x or more, about 10x or more, about 10.5x or more, about 11x or more, about 11.5x or more, about 12x or more, about 12.5x or more, about 13x or more, about 15x or more, about 16x or more, about 17x or more, about 18 times or more, about 19 times or more, about 20 times or more, about 22 times or more, about 24 times or more, about 25 times or more, about 26 times or more, about 28 times or more, about 30 times or more, about 35 times or more, about 40 times or more, about 45 times or more, about 50 times or more, about 55 times or more, about 60 times or more, about 65 times or more, about 70 times or more, about 75 times or more, about 80 times or more, about 85 times or more, about 90 times or more, about 95 times or more, or about 100 times or more. In addition, for example, when the content of the above-mentioned component in the dried leaves of the population of the plant body B of the present invention and the content of the above-mentioned component in the dried leaves of the population of the control stevia plant body are tested by Welch's t-test, the mean value of the former is greater than the mean value of the latter, and the P value of the two-sided test is less than 0.05, preferably less than 0.01, and particularly preferably less than 0.005. The contents to be compared may be the mean values ​​of multiple individuals. In some embodiments, the content of RebE in the dried leaves of the plant B of the present invention is about 3 times or more, about 5 times or more, about 7 times or more, about 9 times or more, about 10 times or more, about 11 times or more, about 12 times or more, about 13 times or more, about 15 times or more, about 16 times or more, about 17 times or more, about 18 times or more, about 19 times or more, about 20 times or more, about 22 times or more, about 24 times or more, about 26 times or more, about 28 times or more, about 30 times or more, about 35 times or more, about 40 times or more, about 45 times or more, about 50 times or more, about 55 times or more, about 60 times or more, about 65 times or more, about 70 times or more, about 75 times or more, or about 80 times or more than the content of the control Stevia plant. In some embodiments, the content of ST in the dried leaves of the plant B of the present invention is more than 1-fold, about 1.2-fold or more, about 1.4-fold or more, about 1.6-fold or more, about 1.8-fold or more, about 2-fold or more, about 2.2-fold or more, about 2.4-fold or more, about 2.6-fold or more, about 2.8-fold or more, about 3-fold or more, about 3.2-fold or more, about 3.4-fold or more, about 3.6-fold or more, about 3.8-fold or more, about 4-fold or more, about 4.5-fold or more, about 5-fold or more, about 5.5-fold or more, about 6-fold or more, about 6.5-fold or more, about 7-fold or more, about 7.5-fold or more, about 8-fold or more, about 8.5-fold or more, about 9-fold or more, about 9.5-fold or more, about 10-fold or more, about 10.5-fold or more, about 11-fold or more, about 11.5-fold or more, about 12-fold or more, about 12.5-fold or more, or about 13-fold or more of the content of ST in the control Stevia plant. In some embodiments, the content of TSG in the dried leaves of the plant B of the present invention is more than 1-fold, about 1.04-fold or more, about 1.06-fold or more, about 1.08-fold or more, about 1.1-fold or more, about 1.12-fold or more, about 1.14-fold or more, about 1.16-fold or more, about 1.17-fold or more, about 1.18-fold or more, about 1.19-fold or more, about 1.2-fold or more, about 1.3-fold or more, about 1.4-fold or more, about 1.5-fold or more, about 1.6-fold or more, about 1.7-fold or more, about 1.8-fold or more, about 1.9-fold or more, about 2-fold or more, about 2.1-fold or more, about 2.2-fold or more, about 2.3-fold or more, about 2.4-fold or more, about 2.5-fold or more, about 2.6-fold or more, about 2.7-fold or more, about 2.8-fold or more, about 2.9-fold or more, or about 3-fold or more of the content of the control Stevia plant. In some embodiments, the plant B of the present invention contains less of at least one steviol glycoside selected from RebA, RebB, RebC, RebD, RebF, RebG, RebM, and RebN than a control Stevia plant not having the genetic characteristic of the present invention. Hereinafter, this trait may be referred to as the "chemical characteristic B2 of the present invention." In addition, a trait containing less RebA than the control stevia plant may be referred to as "chemical feature B2-1 of the present invention", a trait containing less RebB than the control stevia plant may be referred to as "chemical feature B2-2 of the present invention", a trait containing less RebC than the control stevia plant may be referred to as "chemical feature B2-3 of the present invention", a trait containing less RebD than the control stevia plant may be referred to as "chemical feature B2-4 of the present invention", a trait containing less RebF than the control stevia plant may be referred to as "chemical feature B2-5 of the present invention", a trait containing less RebG than the control stevia plant may be referred to as "chemical feature B2-6 of the present invention", a trait containing less RebM than the control stevia plant may be referred to as "chemical feature B2-7 of the present invention", and a trait containing less RebN than the control stevia plant may be referred to as "chemical feature B2-8 of the present invention". "Containing less than a control stevia plant" means, for example, that the content of the above-mentioned component (e.g., the content in dried leaves) is less than that of a control stevia plant when cultivated under the same cultivation conditions, preferably statistically significantly less. More specifically, for example, when cultivated under the same cultivation conditions, the content of the above-mentioned component in dried leaves is less than 1-fold, about 0.9-fold or less, about 0.8-fold or less, about 0.7-fold or less, about 0.6-fold or less, about 0.5-fold or less, about 0.45-fold or less, about 0.4-fold or less, about 0.35-fold or less, about 0.3-fold or less, about 0.25-fold or less, about 0.2-fold or less, about 0.18-fold or less, about 0.16-fold or less than the content in the control stevia plant. , about 0.15 times or less, about 0.14 times or less, about 0.13 times or less, about 0.12 times or less, about 0.11 times or less, about 0.1 times or less, about 0.09 times or less, about 0.08 times or less, about 0.07 times or less, about 0. 06 times or less, approximately 0.05 times or less, approximately 0.045 times or less, approximately 0.04 times or less, approximately 0.035 times or less, approximately 0.03 times or less, approximately 0.025 times or less, approximately 0.024 times or less, approximately 0.023 times or less, approximately 0 .022 times or less, approximately 0.021 times or less, approximately 0.02 times or less, approximately 0.019 times or less, approximately 0.018 times or less, approximately 0.017 times or less, approximately 0.016 times or less, approximately 0.015 times or less, approximately 0.014 times Less than or equal to approximately 0.013 times, less than or equal to approximately 0.012 times, less than or equal to approximately 0.011 times, less than or equal to approximately 0.01 times, less than or equal to approximately 0.009 times, less than or equal to approximately 0.0095 times, less than or equal to approximately 0.009 times, less than or equal to approximately 0.0085 times, It means about 0.008 times or less, about 0.0075 times or less, about 0.007 times or less, about 0.0065 times or less, about 0.006 times or less, about 0.0055 times or less, about 0.005 times or less, about 0.0045 times or less, about 0.004 times or less, about 0.0035 times or less, about 0.003 times or less, about 0.0025 times or less, about 0.002 times or less, about 0.0015 times or less, or about 0.001 times or less. It also means that, for example, when the content of the above-mentioned component in the dried leaves of the population of the plant body B of the present invention and the content of the above-mentioned component in the dried leaves of the population of the control stevia plant body are tested by Welch's t-test, the average value of the former is smaller than the average value of the latter, and the P value of the two-sided test is less than 0.05, preferably less than 0.01, and particularly preferably less than 0.005. The content to be compared may be the average value of multiple individuals. In some embodiments, the content of RebA in the dried leaves of the plant B of the present invention is about 0.02 times or less, about 0.019 times or less, about 0.018 times or less, about 0.017 times or less, about 0.016 times or less, about 0.015 times or less, about 0.014 times or less, about 0.013 times or less, about 0.012 times or less, about 0.011 times or less, about 0.01 times or less, about 0.0095 times or less, about 0.009 times or less than the content of the control Stevia plant. about 0.0085 times or less, about 0.008 times or less, about 0.0075 times or less, about 0.007 times or less, about 0.0065 times or less, about 0.006 times or less, about 0.0055 times or less, about 0.005 times or less, about 0.0045 times or less, about 0.004 times or less, about 0.0035 times or less, about 0.003 times or less, about 0.0025 times or less, about 0.002 times or less, about 0.0015 times or less, or about 0.001 times or less. In some embodiments, the content of RebB in the dried leaves of the plant B of the present invention is about 0.04 times or less, about 0.038 times or less, about 0.036 times or less, about 0.034 times or less, about 0.032 times or less, about 0.03 times or less, about 0.028 times or less, about 0.026 times or less, about 0.024 times or less, about 0.022 times or less, about 0.02 times or less of the content of RebB in the dried leaves of the plant B of the present invention. , about 0.018 times or less, about 0.016 times or less, about 0.014 times or less, about 0.012 times or less, about 0.011 times or less, about 0.01 times or less, about 0.009 times or less, about 0.008 times or less, about 0.007 times or less, about 0.006 times or less, about 0.005 times or less, about 0.004 times or less, about 0.003 times or less, about 0.002 times or less, or about 0.001 times or less. In some embodiments, the content of RebC in the dried leaves of the plant B of the present invention is about 0.5 times or less, about 0.45 times or less, about 0.4 times or less, about 0.35 times or less, about 0.3 times or less, about 0.28 times or less, about 0.26 times or less, about 0.24 times or less, about 0.22 times or less, about 0.2 times or less, about 0.18 times or less, about 0.16 times or less, about 0.14 times or less, about 0.12 times or less, about 0.1 times or less, about 0.09 times or less, about 0.08 times or less, about 0.07 times or less, about 0.06 times or less, about 0.05 times or less, about 0.04 times or less, about 0.03 times or less, about 0.02 times or less, about 0.015 times or less, about 0.01 times or less, or about 0.005 times or less of the content of RebC in the control Stevia plant. In some embodiments, the content of RebD in the dried leaves of the plant B of the present invention is about 0.05 times or less, about 0.045 times or less, about 0.04 times or less, about 0.035 times or less, about 0.03 times or less, about 0.025 times or less, about 0.024 times or less, about 0.023 times or less, about 0.022 times or less, about 0.021 times or less, about 0.02 times or less, about 0.019 or less, about 0.018 or less, about 0.017 or less, about 0.016 or less, about 0.015 or less, about 0.014 or less, about 0.013 or less, about 0.012 or less, about 0.011 or less, about 0.01 or less, about 0.009 or less, about 0.008 or less, about 0.007 or less, about 0.006 or less, or about 0.005 or less. In some embodiments, the content of RebF in the dried leaves of the plant B of the present invention is about 0.03 times or less, about 0.028 times or less, about 0.026 times or less, about 0.024 times or less, about 0.022 times or less, about 0.02 times or less, about 0.019 times or less, about 0.018 times or less, about 0.017 times or less, about 0.016 times or less, about 0.0 It is 15 times or less, about 0.014 times or less, about 0.013 times or less, about 0.012 times or less, about 0.011 times or less, about 0.01 times or less, about 0.009 times or less, about 0.008 times or less, about 0.007 times or less, about 0.006 times or less, about 0.005 times or less, about 0.004 times or less, about 0.003 times or less, about 0.002 times or less, or about 0.001 times or less. In some embodiments, the content of RebG in the dried leaves of the plant B of the present invention is about 0.5 times or less, about 0.45 times or less, about 0.4 times or less, about 0.35 times or less, about 0.3 times or less, about 0.25 times or less, about 0.2 times or less, about 0.18 times or less, about 0.16 times or less, about 0.15 times or less, about 0.14 times or less, about 0.13 times or less, about 0.12 times or less, about 0.11 times or less, about 0.1 times or less, about 0.09 times or less, about 0.08 times or less, about 0.07 times or less, about 0.06 times or less, about 0.05 times or less, about 0.04 times or less, about 0.03 times or less, about 0.02 times or less, or about 0.01 times or less of the content of RebG in the control Stevia plant. In some embodiments, the content of RebM in the dried leaves of the plant B of the present invention is about 0.06 times or less, about 0.055 times or less, about 0.05 times or less, about 0.045 times or less, about 0.04 times or less, about 0.035 times or less, about 0.03 times or less, about 0.025 times or less, about 0.02 times or less, about 0.015 times or less, about 0.014 times or less, about 0.013 times or less, about 0.012 times or less, about 0.011 times or less, about 0.01 times or less, about 0.009 times or less, about 0.008 times or less, about 0.007 times or less, about 0.006 times or less, about 0.005 times or less, about 0.004 times or less, about 0.003 times or less, about 0.002 times or less, or about 0.001 times or less of the content of RebM in the control Stevia plant. In some embodiments, the content of RebN in the dried leaves of the plant B of the present invention is about 0.25 times or less, about 0.2 times or less, about 0.18 times or less, about 0.16 times or less, about 0.14 times or less, about 0.12 times or less, about 0.1 times or less, about 0.095 times or less, about 0.09 times or less, about 0.085 times or less, about 0.08 times or less, about 0.075 times or less, about 0.07 times or less, about 0.065 times or less, about 0.06 times or less, about 0.055 times or less, about 0.05 times or less, about 0.045 times or less, about 0.04 times or less, about 0.035 times or less, about 0.03 times or less, about 0.025 times or less, about 0.02 times or less, about 0.015 times or less, or about 0.01 times or less of the content of the control Stevia plant. In some embodiments, plant B of the present invention expresses UGT76G1-1 less than a control Stevia plant not having the genetic trait of the present invention. Hereinafter, this trait may be referred to as "chemical trait B3 of the present invention." "Expressed less than in a control stevia plant" means, for example, that when grown under the same cultivation conditions, the expression level of the gene (e.g., the expression level in dried leaves) is less than in a control stevia plant, preferably statistically significantly less. More specifically, for example, when cultivated under the same cultivation conditions, it means that the expression level of the above gene in the dried leaves is less than 1-fold, about 0.5-fold or less, about 0.45-fold or less, about 0.4-fold or less, about 0.35-fold or less, about 0.3-fold or less, about 0.25-fold or less, about 0.2-fold or less, about 0.18-fold or less, about 0.17-fold or less, about 0.16-fold or less, about 0.15-fold or less, about 0.14-fold or less, about 0.13-fold or less, about 0.12-fold or less, about 0.11-fold or less, about 0.1-fold or less, about 0.09-fold or less, about 0.08-fold or less, about 0.07-fold or less, about 0.06-fold or less, about 0.05-fold or less, about 0.04-fold or less, about 0.03-fold or less, or about 0.02-fold or less of the expression level in the control stevia plant. Furthermore, for example, when the expression level of the above gene in dried leaves in a population of plant B of the present invention and the expression level of the above gene in dried leaves in a population of control stevia plants are tested by Welch's t-test, the average value of the former is smaller than the average value of the latter, and the P value of the two-sided test is less than 0.05, preferably less than 0.01, and particularly preferably less than 0.005. In some embodiments, the plant B of the present invention contains about 2.9% or more RebE per unit mass of dry leaves. Hereinafter, this trait may be referred to as "chemical feature B4 of the present invention". For example, the plant B of the present invention contains about 3% or more, about 3.1% or more, about 3.2% or more, about 3.3% or more, about 3.4% or more, about 3.5% or more, about 3.6% or more, about 3.7% or more, about 3.8% or more, about 3.9% or more, about 4% or more, about 4.1% or more, about 4.2% or more, about 4.3% or more, about 4.4% or more, about 4.5% or more, about 4.6% or more, about 4.7% or more, about 4.8% or more, about 4. 9% or more, about 5% or more, about 5.1% or more, about 5.2% or more, about 5.3% or more, about 5.4% or more, about 5.5% or more, about 5.6% or more, about 5.7% or more, about 5.8% or more, about 5.9% or more, about 6% or more, about 6.1% or more, about 6.2% or more, about 6.3% or more, about 6.4% or more, about 6.5% or more, about 6.6% or more, about 6.7% or more, about 6.8% or more, about 6.9% or more, or about 7% or more of RebE. The upper limit of the RebE content is not particularly limited, and may be, for example, about 8%, about 9%, about 10%, about 11%, about 12%, etc. per unit mass of the dried leaves. In some embodiments, the total content of RebE and ST in plant B of the present invention is about 11.2% or more per unit mass of dry leaves. Hereinafter, this trait may be referred to as "chemical feature B5 of the present invention." For example, the total content of RebE and ST in plant B of the present invention is about 11.3% or more, about 11.4% or more, about 11.5% or more, about 11.6% or more, about 11.8% or more, about 12% or more, about 12.2% or more, about 12.4% or more, about 12.6% or more, about 12.8% or more, about 13% or more, about 13.2% or more, about 13.4% or more, about 13.6% or more, about 13.8% or more, about 14% or more per unit mass of dry leaves. , about 14.2% or more, about 14.4% or more, about 14.6% or more, about 14.8% or more, about 15% or more, about 15.2% or more, about 15.4% or more, about 15.6% or more, about 15.8% or more, about 16% or more, about 16.2% or more, about 16.4% or more, about 16.6% or more, about 16.8% or more, about 17% or more, about 17.2% or more, about 17.4% or more, about 17.6% or more, about 17.8% or more, or about 18% or more. The upper limit of the total content of RebE and ST is not particularly limited, and may be, for example, about 19%, about 20%, about 25%, about 30%, about 40%, etc. per unit mass of dried leaves. In some embodiments, the ratio of the RebE content to the RebA content per unit mass of dry leaves in plant B of the present invention (RebE / RebA) is 100 or more. Hereinafter, this trait may be referred to as "chemical feature B6 of the present invention." For example, the ratio in plant B of the present invention is about 100 or more, about 125 or more, about 150 or more, about 175 or more, about 200 or more, about 225 or more, about 250 or more, about 255 or more, about 260 or more, about 275 or more, about 300 or more, about 325 or more, about 350 or more, about 375 or more, about 400 or more, about 425 or more, about 450 or more, about 475 or more, about 500 or more, about 525 or more, about 527 or more, about 528 or more, about 529 or more, about 530 or more, about 532 or more, about 534 or more, about 536 or more, about 538 or more, about 540 or more, or about 540 or more. or above, about 542 or more, about 544 or more, about 546 or more, about 548 or more, about 550 or more, about 552 or more, about 554 or more, about 556 or more, about 558 or more, about 560 or more, about 562 or more, about 564 or more, about 566 or more, about 568 or more, about 570 or more, about 571 or more, about 572 or more, about 573 or more, about 574 or more, about 575 or more, about 576 or more, about 577 or more, about 578 or more, about 579 or more, about 580 or more, about 582 or more, about 584 or more, about 586 or more, about 588 or more, about 590 or more, or about 600 or more. The upper limit of the ratio is not particularly limited, and may be, for example, about 625, about 650, about 700, about 725, about 750, etc. In preferred embodiments, the ratio is about 528 or more, about 529 or more, about 530 or more, about 532 or more, about 534 or more, about 536 or more, about 538 or more, about 540 or more, about 542 or more, about 544 or more, about 546 or more, about 548 or more, about 550 or more, about 552 or more, about 554 or more, about 556 or more, about 558 or more, about 560 or more, about 562 or more, about 564 or more, about 566 or more, about 568 or more, about 570 or more, about 571 or more, about 572 or more, about 573 or more, about 574 or more, about 575 or more, about 576 or more, about 577 or more, about 578 or more, about 579 or more, about 580 or more, about 582 or more, about 584 or more, about 586 or more, about 588 or more, about 590 or more, or about 600 or more. In certain embodiments, the ratio is about 573 or greater. Plant B of the present invention may have a combination of two or more of the above chemical characteristics. For example, plant B of the present invention may have at least two of the chemical characteristics B1-1 to B1-3, B2-1 to B2-8, and B3 to B6 of the present invention (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15 of these chemical characteristics). In a preferred embodiment, plant B of the present invention has at least both chemical characteristics B4 and B5 of the present invention. 1-3. Stevia plants with high RebE and ST contents In another aspect, the present invention provides a stevia plant containing 2.9% or more RebE per unit mass of dried leaves and having a total content of RebE and ST per unit mass of dried leaves of 11.2% or more (hereinafter, sometimes referred to as "plant C of the present invention" or "Stevia plant C of the present invention"). "Containing 2.9% or more RebE per unit mass of dried leaves" means, for example, that a given mass of dried leaves (e.g., 50 mg) contains RebE at a ratio of 2.9% by mass or more (e.g., 1.45 mg or more). Similarly, "the total content of RebE and ST per unit mass of dried leaves is 11.2% or more" means, for example, that a given mass of dried leaves contains RebE and ST at a ratio of 11.2% by mass or more in total. In this embodiment, the proportion of RebE per unit mass of dried leaves is, but not limited to, for example, about 2.9% or more, about 3% or more, about 3.1% or more, about 3.2% or more, about 3.3% or more, about 3.4% or more, about 3.5% or more, about 3.6% or more, about 3.7% or more, about 3.8% or more, about 3.9% or more, about 4% or more, about 4.1% or more, about 4.2% or more, about 4.3% or more, about 4.4% or more, about 4.5% or more, about 4.6% or more, about 4.7% or more. , about 4.8% or more, about 4.9% or more, about 5% or more, about 5.1% or more, about 5.2% or more, about 5.3% or more, about 5.4% or more, about 5.5% or more, about 5.6% or more, about 5.7% or more, about 5.8% or more, about 5.9% or more, about 6% or more, about 6.1% or more, about 6.2% or more, about 6.3% or more, about 6.4% or more, about 6.5% or more, about 6.6% or more, about 6.7% or more, about 6.8% or more, about 6.9% or more, or about 7% or more, etc. The upper limit of the RebE content is not particularly limited, and may be, for example, about 8%, about 9%, about 10%, about 11%, about 12%, etc. per unit mass of the dried leaves. In addition, the combined ratio of RebE and ST per unit mass of dried leaves in this embodiment is not limited, and may be, for example, about 11.2% or more, about 11.3% or more, about 11.4% or more, about 11.5% or more, about 11.6% or more, about 11.8% or more, about 12% or more, about 12.2% or more, about 12.4% or more, about 12.6% or more, about 12.8% or more, about 13% or more, about 13.2% or more, about 13.4% or more, about 13.6% or more, or about 13.8% or more. , about 14% or more, about 14.2% or more, about 14.4% or more, about 14.6% or more, about 14.8% or more, about 15% or more, about 15.2% or more, about 15.4% or more, about 15.6% or more, about 15.8% or more, about 16% or more, about 16.2% or more, about 16.4% or more, about 16.6% or more, about 16.8% or more, about 17% or more, about 17.2% or more, about 17.4% or more, about 17.6% or more, about 17.8% or more, or about 18% or more, etc. The upper limit of the total content of RebE and ST is not particularly limited, and may be, for example, about 19%, about 20%, about 25%, about 30%, about 40%, etc. per unit mass of dried leaves. Plant C of the present invention may have genetic characteristic (6). Plant C of the present invention may further have at least one of chemical characteristics B1-1 to B1-3, B2-1 to B2-8, B3, and B6 of the present invention (for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 of these chemical characteristics). In this specification, the plants A, B and C of the present invention may be collectively referred to as "the plant of the present invention" or "the stevia plant of the present invention." The plant body of the present invention may include not only the entire plant body, but also parts or derivatives thereof, such as plant organs (e.g., leaves, petals, stems, roots, seeds, etc.), plant tissues (e.g., epidermis, phloem, parenchyma, xylem, vascular bundles, palisade tissue, spongy tissue, etc.), or various forms of plant cells (e.g., suspension culture cells), protoplasts, leaf slices, callus, etc. The plant body of the present invention may also include tissue cultures or plant cultured cells. This is because a plant body can be regenerated by culturing such tissue cultures or plant cultured cells. Examples of the plant body tissue cultures or plant cultured cells of the present invention include, but are not limited to, embryos, meristematic cells, pollen, leaves, roots, root tips, petals, protoplasts, leaf slices, and callus. 2. Method for producing the plant of the present invention In another aspect, the present invention provides a method for producing a stevia plant which contains at least one steviol glycoside selected from RebD, RebE, RebN, and ST in a greater amount than a control stevia plant not having the genetic characteristics (1) to (5), and / or contains at least one steviol glycoside selected from RebA and RebG in a lesser amount than the control stevia plant, and / or has a lower expression level of a UGT76G1 family member selected from UGT76G1-1 and UGT76G1-4 than the control stevia plant, the method comprising the step of crossing a stevia plant A of the present invention with a second stevia plant (hereinafter, this may be referred to as "production method A of the present invention"). A stevia plant produced by this method can have the same genetic characteristics as plant A of the present invention. The range of the steviol glycoside content in the plant obtained by the production method A of the present invention relative to the content in the control stevia plant, the range of the expression level of the UGT76G1 family relative to the expression level in the control stevia plant, etc. are as described above for the plant A of the present invention. In another aspect, the present invention provides a method for producing a stevia plant according to the present invention, comprising the step of crossing the stevia plant B or C of the present invention with a second stevia plant, the second stevia plant being (1) a stevia plant having a higher content of at least one steviol glycoside selected from RebE, ST, and TSG than a control stevia plant not having the genetic characteristic (6), and / or (2) a stevia plant having a lower content of at least one steviol glycoside selected from RebA, RebB, RebC, RebD, RebF, RebG, RebM, and RebN than the control stevia plant, and / or (3) a stevia plant having a higher content of UGT76G1-1 than the control stevia plant. The present invention provides a method for producing a stevia plant having an expression level lower than that of the control stevia plant, and / or (4) containing 2.9% or more of RebE per unit mass of dried leaves and having a total content of RebE and ST of 11.2% or more per unit mass of dried leaves, and / or (5) a ratio of the RebE content to the RebA content per unit mass of dried leaves of 100 or more (hereinafter, this method may be referred to as "production method B of the present invention"). (Hereinafter, "production method A of the present invention" and "production method B of the present invention" may be collectively referred to as "production methods of the present invention"). A stevia plant produced by this method can have the same genetic characteristics as plant B of the present invention. The range of the steviol glycoside content in the plant obtained by the production method B of the present invention relative to the content in the control stevia plant, the range of the expression level of UGT76G1-1 relative to the expression level in the control stevia plant, the range of the RebE content, the range of the total content of RebE and ST, the range of the ratio of the RebE content to the RebA content, etc. are as described above for the plant B of the present invention. In the production method of the present invention, "crossing" means crossing a plant of the present invention (first generation (S1)) with a second plant (S1) to obtain a child plant (a plant produced by the production method of the present invention (second generation (S2)). Backcrossing is preferred as the crossing method. "Backcrossing" is a technique in which a child plant (S2) born between a plant of the present invention and a second plant is further crossed with a plant of the present invention (i.e., a plant having the genetic characteristics of the present invention) (S1) to produce a plant having the genetic characteristics of the present invention. When the second plant (S1) used in the production method of the present invention has the same genetic characteristics as the plant of the present invention, it is essentially backcrossing. Alternatively, the plant of the present invention can be produced by self-pollination, which can be carried out by self-pollinating the pistil of the plant of the present invention with pollen from the stamen of the plant of the present invention. Since the plant produced by the production method of the present invention may have the same genetic characteristics as the plant of the present invention, it is possible to produce a stevia plant having a phenotype equivalent to the plant of the present invention by further crossing the plant produced by the production method of the present invention with a third stevia plant. In another embodiment, the plant of the present invention can be produced by regenerating the plant by culturing the above-mentioned tissue culture or plant cell culture. The culturing conditions are the same as those for culturing tissue culture or plant cell culture of wild-type Stevia plants and are known (Protocols for In Vitro cultures and secondary metabolite analysis of aromatic and medicinal plants, Method in molecular biology, vol. 1391, pp113-123). In yet another embodiment, the plant of the present invention can be produced by introducing the mutation of the present invention or a mutation having an equivalent effect into the genome of a stevia plant. Mutation (1) of the present invention causes a frameshift from position 842 to the 3' side of SEQ ID NO:1, so that TAG at positions 846 to 848 becomes a stop codon. Mutation (2) of the present invention causes a frameshift from position 955 to the 3' side of SEQ ID NO:1, so that TGA at positions 1001 to 1003 becomes a stop codon. Mutation (3) of the present invention causes a frameshift from position 1340 to the 3' side of SEQ ID NO:1, so that TAA at positions 1369 to 1371 is no longer a stop codon. Mutation (4) of the present invention causes a frameshift from position 711 to the 3' side of SEQ ID NO:2, so that TGA at positions 728 to 730 becomes a stop codon. Mutation (5) of the present invention changes the codon TCG at positions 823 to 825 of SEQ ID NO:2 to the stop codon TAG. Mutation (6) of the present invention changes the codon TAT at positions 607 to 609 of SEQ ID NO:3 to the stop codon TAA. Without wishing to be bound by a particular theory, among the mutations in SEQ ID NO:1, the mutation (3) of the present invention has the smallest effect on the amino acid sequence, and therefore any mutation that has a greater effect on the amino acid sequence is considered to have an effect equivalent to the mutations (1) to (3) of the present invention. Similarly, among the mutations in SEQ ID NO:2, the mutation (5) of the present invention has the smallest effect on the amino acid sequence, and therefore any mutation that has a greater effect on the amino acid sequence is considered to have an effect equivalent to the mutations (3) to (4) of the present invention. Thus, the "mutation having an effect equivalent to that of the mutation of the present invention" in plant A of the present invention may be, for example, at least one of (a) a nonsense mutation or frameshift mutation at a position 5' to the position corresponding to position 1341 of SEQ ID NO:1, and (b) a nonsense mutation or frameshift mutation at a position 5' to the position corresponding to position 824 of SEQ ID NO:2. In some aspects, the "mutation having an effect equivalent to that of the mutation of the present invention" in plant A of the present invention may be at least one of: (a') a nonsense mutation or a frameshift mutation in a position 5' to the position corresponding to position 956 of SEQ ID NO:1; (a'') a nonsense mutation or a frameshift mutation in a position 5' to the position corresponding to position 841 of SEQ ID NO:1; and (b') a nonsense mutation or a frameshift mutation in a position 5' to the position corresponding to position 712 of SEQ ID NO:2. A "mutation having an effect equivalent to that of the mutation of the present invention" in plants B and C of the present invention may be, for example, a nonsense mutation or frameshift mutation at a position 5' to the position corresponding to position 609 of SEQ ID NO:3. Mutations may be introduced by recombinant DNA techniques or non-recombinant techniques. An example of a "recombinant technique" is a method of introducing a desired mutation into the genome of a host cell (or a host plant) by genome editing or the like. An example of a "non-recombinant technique" is a method of inducing a mutation in a gene of a host cell (or a host plant) without introducing a foreign gene. Such a method includes a method of applying a mutagen to a plant cell. Examples of such a mutagen include ethyl methanesulfonate (EMS) and sodium azide. For example, EMS can be used to treat plant cells at concentrations of 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1%, 2%, and the like. The treatment time is 1 to 48 hours, 2 to 36 hours, 3 to 30 hours, 4 to 28 hours, 5 to 26 hours, or 6 to 24 hours. The treatment procedure itself is known, and can be carried out, for example, by immersing the water-absorbed seeds that have undergone the water absorption process in a treatment solution containing the mutagen at the above concentration for the treatment time described above. Alternatively, as an example of a non-genetic recombination technique, a method can be used in which plant cells are irradiated with radiation or light such as X-rays, gamma rays, ion beams (e.g., heavy ion beams), ultraviolet rays, etc. In this case, for example, cells irradiated with an appropriate amount of ultraviolet light (ultraviolet lamp strength, distance, time) can be cultured in a selection medium, etc., and then cells, calli, or plants having the desired traits can be selected. The irradiation intensity is 0.01-100Gr, 0.03-75Gr, 0.05-50Gr, 0.07-25Gr, 0.09-20Gr, 0.1-15Gr, 0.1-10Gr, 0.5-10Gr, 1-10Gr, the irradiation distance is 1cm-200m, 5cm-100m, 7cm-75m, 9cm-50m, 10cm-30m, 10cm-20m, 10cm-10m, and the irradiation time is 1min-2years, 2min-1year, 3min-0.5years, 4min-1month, 5min-2weeks, 10min-1week. The irradiation intensity, distance and time vary depending on the type of radiation and the state of the target of irradiation (cells, callus, plant body), but can be adjusted appropriately by a person skilled in the art. In addition, techniques such as cell fusion, anther culture (haploid cultivation), and distant crossing (haploid cultivation) are also known. In general, plant cells may undergo mutations during cultivation, and therefore it is preferable to reinstate them into an individual plant for more stable maintenance of traits. Plants obtained by subsequently subjecting the plant body of the present invention to genetic modification (e.g., by genome editing, etc.) using the plant body of the present invention as a host (e.g., a plant body obtained by subjecting the plant body of the present invention as a host to genetic modification to further impart another trait) are not excluded from the scope of the present invention. The plant body of the present invention may be one obtained by genetic recombination techniques or its progeny (hereinafter sometimes referred to as a "genetically modified plant body"), or one obtained by non-genetically modified techniques or its progeny (hereinafter sometimes referred to as a "non-genetically modified plant body"). 3. Screening method for plants according to the present invention The plant of the present invention and plants having the same genetic characteristics as the plant of the present invention can be screened by detecting the genetic characteristics of the present invention from tissues of a test plant. Here, "screening" means distinguishing the plant of the present invention from other plants and selecting the plant of the present invention. Therefore, in another aspect, the present invention provides a method for screening the stevia plant A of the present invention, which comprises a step of detecting the presence of at least one of the genetic characteristics (1) to (5) from a test stevia plant (hereinafter, this may be referred to as "screening method A of the present invention"), and a method for screening the stevia plants B and C of the present invention, which comprises a step of detecting the presence of the genetic characteristic (6) from a test stevia plant (hereinafter, this may be referred to as "screening method B of the present invention") (hereinafter, "screening method A of the present invention" and "screening method B of the present invention" may be collectively referred to as "screening methods of the present invention"). In some embodiments of the screening method A of the present invention, the genetic features to be detected are any one, any two (e.g., genetic features (1)+(2), (1)+(3), (1)+(4), (1)+(5), (2)+(3), (2)+(4), (2)+(5), (3)+(4), (3)+(5) or (4)+(5)) of the genetic features (1) to (5), or any three (e.g., genetic features (1)+(2)+(3), (1)+(2)+(4), (1) +(2)+(5), (1)+(3)+(4), (1)+(3)+(5), (1)+(4)+(5), (2)+(3)+(4), (2)+(3)+(5), (2)+(4)+(5), or (3)+(4)+(5)), any four (e.g., genetic characteristics (1)+(2)+(3)+(4), (1)+(2)+(3)+(5), (1)+(2)+(4)+(5), or (2)+(3)+(4)+(5)), or all of the genetic characteristics (1) through (5). In certain embodiments, the genetic feature to be detected is genetic feature (1), genetic feature (3), genetic feature (4), a combination of genetic features (1) and (2), a combination of genetic features (1) and (3), a combination of genetic features (3) and (4), or a combination of genetic features (3) and (5). In a preferred embodiment, the genetic feature to be detected is genetic feature (4) or a combination of genetic feature (4) with another genetic feature (e.g., a combination of genetic features (3) and (4)). Specific examples of the method for detecting the presence of the genetic features of the present invention are as described in the section on plants of the present invention. The screening method of the present invention may further include a step of selecting a plant in which the presence of at least one of the above genetic features is detected from among the test plants. The presence of the genetic feature (1) of the present invention can be determined by detecting an allele in which the sequence corresponding to positions 841-842 of SEQ ID NO:1 is AAG (e.g., an allele containing the base sequence of SEQ ID NO:14-16, 35, 41, 43, or 47). The presence of genetic feature (2) of the present invention can be determined by detecting an allele in which the sequence corresponding to positions 953 to 964 of SEQ ID NO:1 is GT (e.g., an allele containing the base sequence of SEQ ID NO:17 to 19, 37, 41, 45, or 47). The presence of the genetic feature (3) of the present invention can be determined by detecting an allele in which the sequence corresponding to positions 1338 to 1341 of SEQ ID NO:1 is AG (e.g., an allele containing the base sequence of SEQ ID NO:20 to 22, 39, 43, 45, or 47). The presence of the genetic feature (4) of the present invention can be determined by detecting an allele in which the sequence corresponding to positions 710-711 of SEQ ID NO:2 is TTCCGCCATC (e.g., an allele containing the base sequence of SEQ ID NO:23-25, 49, or 53). The presence of genetic feature (5) of the present invention can be determined by detecting an allele in which the base at the position corresponding to position 824 of SEQ ID NO:2 is A (e.g., an allele containing the base sequence of SEQ ID NO:26 to 28, 51, or 53). The presence of genetic feature (6) of the present invention can be determined by detecting an allele in which the base at the position corresponding to position 609 of SEQ ID NO:3 is A (e.g., an allele containing the base sequence of SEQ ID NO:29 to 31 or 55). The screening method of the present invention may further include a step of evaluating the steviol glycoside content and / or the expression level of the UGT76G1 family of a test stevia plant in which the presence of the genetic feature of the present invention is detected. The evaluation of the steviol glycoside content and the expression level of the UGT76G1 family is as described in the section on the plant of the present invention. In this embodiment, among the test stevia plants in which the genetic feature of the present invention is detected, an individual having a high steviol glycoside content and / or an individual having a low expression level of the UGT76G1 family may be selected and crossed with another stevia plant, and the screening method of the present invention may be applied to the resulting offspring plant. Thus, the screening method of the present invention may include one or more of the following steps. (i) detecting the presence of a genetic feature of the present invention in the genome of a test stevia plant; (ii) evaluating the content of steviol glycosides and / or the expression level of the UGT76G1 family in the test stevia plant tissue in which the presence of the genetic feature of the present invention has been detected; (iii) selecting, from among the test stevia plants in which the presence of the genetic feature of the present invention has been detected, individuals having a high content of steviol glycosides and / or individuals having a low expression level of the UGT76G1 family; (iv) crossbreeding the selected individuals with other stevia plants; (v) detecting the presence of the genetic feature of the present invention in the genome of the offspring plant obtained by crossing; (vi) evaluating the steviol glycoside content and / or the expression level of the UGT76G1 family in offspring tissue in which the presence of the genetic feature of the present invention has been detected; (vii) A step of selecting individuals having a high steviol glycoside content and / or a low expression level of the UGT76G1 family from among the offspring plants in which the presence of the genetic features of the present invention has been detected. The selected individual with a high steviol glycoside content may be, for example, the top 50%, top 40%, top 30%, top 25%, top 20%, top 15%, top 10%, top 5%, top 4%, top 3%, top 2%, top 1%, etc., individuals with high steviol glycoside content among the test stevia plants in which the presence of the genetic feature of the present invention was detected. The selected individual with a low expression level of the UGT76G1 family may be, for example, the top 50%, top 40%, top 30%, top 25%, top 20%, top 15%, top 10%, top 5%, top 4%, top 3%, top 2%, top 1%, etc., individuals with low expression level of the UGT76G1 family among the test stevia plants in which the presence of the genetic feature of the present invention was detected. In addition, the other stevia plant to be crossed may or may not have the genetic characteristic of the present invention. In the above embodiment, steps (iv) to (vii) can be repeated multiple times. In this manner, stevia plants having a higher content of steviol glycosides and / or a lower expression level of the UGT76G1 family can be screened. The steviol glycoside to be evaluated may be, for example, at least one selected from RebD, RebE, RebN, and ST for screening method A of the present invention, and at least one selected from RebE, ST, and TSG for screening method B of the present invention. The UGT76G1 family to be evaluated may be, for example, at least one selected from UGT76G1-1 and UGT76G1-4 for screening method A of the present invention, and UGT76G1-1 for screening method B of the present invention. In the screening method of the present invention, the test stevia plant may be a natural plant, a non-transgenic plant, or a transgenic plant. The non-transgenic plant is as described in the section on the method for producing the plant of the present invention. In the screening method of the present invention, the test stevia plant may include a stevia plant that has been subjected to a mutagenesis treatment and its progeny plants. The mutagenesis treatment is as described in the section on the plant of the present invention, and includes treatment with a mutagen, treatment with radiation or light, etc. 4. Dead tissue or dead cells of the present invention In a further aspect of the present invention, there is provided a dead tissue or cell of the stevia plant of the present invention, a stevia plant selected by the screening method of the present invention, or a stevia plant produced by the production method of the present invention (hereinafter, sometimes referred to as "dead tissue or dead cell of the present invention"). "Dead" means a state in which the plant does not have the ability to reproduce, grow, reproduce, or grow, and includes natural death without artificial manipulation, as well as death due to artificial manipulation such as cutting, crushing, heating (including heating through a gas such as air, heating through a liquid such as water, and heating through steam such as water vapor), freezing, drying, and freeze-drying. Dead tissue means tissue in which all of the cells contained therein are dead. Specific examples of the dead tissue or dead cell of the present invention include dead tissue or cells other than seeds. More specifically, dead embryos, meristematic cells, pollen, leaves, roots, root tips, petals, protoplasts, leaf slices, or calluses are included. Dried leaves are preferred. The dead tissue or dead cells of the present invention can be used as raw materials for the extracts, steviol glycoside purified products, pharmaceuticals, flavorings, foods and beverages, etc. described below. 5. Manufacturing method of plant-derived extract and products using said extract In a further aspect of the present invention, there is provided an extract of a plant, dead tissue or dead cell of the present invention (hereinafter, may be referred to as "the extract of the present invention"), and a method for producing an extract containing steviol glycoside (hereinafter, may be referred to as "the method for producing the extract of the present invention"), which comprises the step of obtaining an extract from a plant of the present invention (e.g., fresh leaves) or dead tissue or dead cell of the plant (e.g., dried leaves). Furthermore, there is provided a method for producing a purified steviol glycoside product (hereinafter, may be referred to as "the method for producing a purified steviol glycoside product of the present invention"), which comprises the step of purifying steviol glycoside from the extract of the present invention or an extract obtained by the method for producing an extract of the present invention. Specifically, there is provided a method for producing a purified steviol glycoside product, the method comprising the steps of obtaining an extract containing the steviol glycoside from the stevia plant of the present invention, a stevia plant selected by the screening method of the present invention, or a stevia plant produced by the production method of the present invention, or a dead tissue or dead cell of the present invention, and purifying the steviol glycoside from the obtained extract. The extract containing the steviol glycosides can be obtained by reacting a plant body of the present invention (e.g., fresh leaves) or a dead tissue or cell of the present invention (e.g., dried leaves) with an appropriate solvent (e.g., an aqueous solvent such as water, or an organic solvent such as alcohol, ether, and acetone). For example, the extraction conditions for steviol glycosides can be referenced to the methods described in Ohta et al. or WO2010 / 038911. In addition, individual steviol glycosides, such as RebA, RebB, RebC, RebD, RebE, RebF, RebG, RebM, RebN, ST, etc., can be purified from the extract containing the above-mentioned steviol glycosides using known methods such as gradients of ethyl acetate or other organic solvents:water, chromatography (e.g., HPLC, UPLC, gas chromatography, etc.), and TOF-MS. One embodiment of the extract of the present invention obtained from plant A of the present invention (hereinafter, may be referred to as "extract A of the present invention") has a higher content of at least one steviol glycoside selected from RebD, RebE, RebN, and ST, and / or a lower content of at least one steviol glycoside selected from RebA and RebG, compared to an extract of a control Stevia plant not having the genetic characteristics (1) to (5). The higher or lower content compared to the control Stevia plant is as described in the section on plant A of the present invention. In one embodiment of the extract of the present invention obtained from plant B or C of the present invention (hereinafter, sometimes referred to as "extract B of the present invention"), the content of at least one steviol glycoside selected from RebE, ST, and TSG is higher and / or the content of at least one steviol glycoside selected from RebA, RebB, RebC, RebD, RebF, RebG, RebM, and RebN is lower than that of an extract of a control Stevia plant not having the genetic characteristic (6). The higher or lower content compared to the control Stevia plant is as described in the section on plant B of the present invention. In one embodiment of the extract B of the present invention, the ratio of the RebE content to the RebA content is 100 or more. For example, the ratio in the extract B of the present invention is about 100 or more, about 125 or more, about 150 or more, about 175 or more, about 200 or more, about 225 or more, about 250 or more, about 255 or more, about 260 or more, about 275 or more, about 300 or more, about 325 or more, about 350 or more, about 375 or more, about 400 or more, about 425 or more, about 450 or more, about 475 or more, about 500 or more, about 525 or more, about 527 or more, about 528 or more, about 529 or more, about 530 or more, about 532 or more, about 534 or more, about 536 or more, about 538 or more, about 540 or more, and the like. or above, about 542 or more, about 544 or more, about 546 or more, about 548 or more, about 550 or more, about 552 or more, about 554 or more, about 556 or more, about 558 or more, about 560 or more, about 562 or more, about 564 or more, about 566 or more, about 568 or more, about 570 or more, about 571 or more, about 572 or more, about 573 or more, about 574 or more, about 575 or more, about 576 or more, about 577 or more, about 578 or more, about 579 or more, about 580 or more, about 582 or more, about 584 or more, about 586 or more, about 588 or more, about 590 or more, or about 600 or more. The upper limit of the ratio is not particularly limited, and may be, for example, about 625, about 650, about 700, about 725, about 750, etc. In preferred embodiments, the ratio is about 528 or more, about 529 or more, about 530 or more, about 532 or more, about 534 or more, about 536 or more, about 538 or more, about 540 or more, about 542 or more, about 544 or more, about 546 or more, about 548 or more, about 550 or more, about 552 or more, about 554 or more, about 556 or more, about 558 or more, about 560 or more, about 562 or more, about 564 or more, about 566 or more, about 568 or more, about 570 or more, about 571 or more, about 572 or more, about 573 or more, about 574 or more, about 575 or more, about 576 or more, about 577 or more, about 578 or more, about 579 or more, about 580 or more, about 582 or more, about 584 or more, about 586 or more, about 588 or more, about 590 or more, or about 600 or more. In certain embodiments, the ratio is about 573 or greater. The extracts of the present invention may have useful properties (e.g., unique sensory properties, etc.) that differ from known extracts of Stevia plants due to their unique steviol glycoside composition. By mixing the extract of the present invention thus obtained and / or the steviol glycoside purified product obtained by the method for producing a steviol glycoside purified product of the present invention with other ingredients, a medicine, flavoring, or food or drink containing steviol glycoside can be produced. Therefore, as another embodiment, the present invention provides a method for producing a medicine, flavoring, or food or drink, which includes a step of mixing the extract of the present invention and / or the steviol glycoside purified product obtained by the method for producing a steviol glycoside purified product of the present invention with other ingredients. Furthermore, the present invention provides a medicine, flavoring, or food or drink containing the steviol glycoside obtained by the above production method. Here, food or drink means beverages and foods. Therefore, in one embodiment, the present invention provides a medicine, flavoring, beverage, or food, and also provides a method for producing the medicine, flavoring, beverage, or food. The present invention also provides a method for producing a steviol glycoside-containing composition, comprising a step of mixing the extract of the present invention and / or a steviol glycoside purified product obtained by the method for producing a steviol glycoside purified product of the present invention with other ingredients. Furthermore, the present invention provides a steviol glycoside-containing composition obtained by the production method, which contains steviol glycoside and other ingredients. The above-mentioned "other ingredients" may include ingredients that are not present in natural stevia plants or non-natural ingredients. Therefore, the composition may be a non-natural composition. The composition may be, for example, a pharmaceutical composition, a flavor composition, a beverage composition, or a food composition. 6. UGT76G1 family In another embodiment, the present invention provides the UGT76G1 family and mutants thereof. Table 1 shows the CDS and amino acid sequences of the UGT76G1 family and mutants thereof. In the table, "WT" means wild type. UGT76G1-1 may have a preference for the conversion of RebE to RebD. 7. Nucleotide sequence related to the plant of the present invention In another embodiment, the present invention provides a nucleotide sequence for the stevia plant of the present invention. The nucleotide sequence for the stevia plant of the present invention comprises or consists of a nucleotide sequence selected from SEQ ID NOs: 1 to 3, 14 to 31, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, and 55. A specific embodiment of the nucleotide sequence for the stevia plant having the genetic characteristic (1) of the present invention comprises or consists of a nucleotide sequence selected from SEQ ID NOs: 14 to 16, 35, 41, 43, and 47. A specific embodiment of the nucleotide sequence for the stevia plant having the genetic characteristic (2) of the present invention comprises or consists of a nucleotide sequence selected from SEQ ID NOs: 17 to 19, 37, 41, 45, and 47. A specific embodiment of the nucleotide sequence for the stevia plant having the genetic characteristic (3) of the present invention comprises or consists of a nucleotide sequence selected from SEQ ID NOs: 20 to 22, 39, 43, 45, or 47. A specific embodiment of the base sequence of the stevia plant having the genetic characteristic (4) of the present invention comprises or consists of a base sequence selected from SEQ ID NOs: 23 to 25, 49, and 53. A specific embodiment of the base sequence of the stevia plant having the genetic characteristic (5) of the present invention comprises or consists of a base sequence selected from SEQ ID NOs: 26 to 28, 51, and 53. A specific embodiment of the base sequence of the stevia plant having the genetic characteristic (6) of the present invention comprises or consists of a base sequence selected from SEQ ID NOs: 29 to 31, and 55. Examples of the present invention will be described below, but the present invention is not limited to these specific embodiments. [Example 1] Identification of mutations associated with high RebD phenotype The steviol glycoside content of 38 stevia strains cultivated at the Suntory World Research Center was measured, and genome sequencing was performed. Specifically, 0.25 g of fresh leaves were sampled from each strain, freeze-dried, and 0.05 g of the crushed dried material was added to 100 times the volume (5 mL) of pure water. Extraction was performed by ultrasonic treatment for 20 minutes, followed by centrifugation and filtration, and the sample solution was diluted 60 times with 32% acetonitrile. LC-MS / MS analysis of 1 mL of this sample solution was performed using the MRM mode of LCMS8050 (Shimadzu), and the concentrations of RebA, RebB, RebC, RebD, RebE, RebF, RebG, RebM, RebN, and ST were quantified. Furthermore, genomic DNA was extracted from the sampled fresh leaves and sequenced using a sequencer (HiSeq 2500, Illumina). PCA analysis was performed based on the data on steviol glycoside content, and the Stevia strains examined were classified into clade A, which had a lower RebD content, and clade B, which had a higher RebD content (Tables 2-3). In the following table, TSG indicates total steviol glycosides. The value of each steviol glycoside is the weight percent in the dry leaves, and the value of TSG is the sum of the values ​​of all measured steviol glycosides (i.e., RebA, RebB, RebC, RebD, RebE, RebF, RebG, RebM, RebN, and ST). When we analyzed the differences in genome sequences between clades A and B, the following genetic features were found only in clade B (Table 4). (1) Heterozygosity for an allele in which the sequence corresponding to positions 841 to 842 of SEQ ID NO:1 is AAG. (2) Heterozygosity for an allele in which the sequence corresponding to positions 953 to 964 of SEQ ID NO:1 is GT. (3) Homozygous or heterozygous for an allele in which the sequence corresponding to positions 1338 to 1341 of SEQ ID NO:1 is AG. (4) Heterozygosity for an allele in which the sequence corresponding to positions 710 to 711 of SEQ ID NO:2 is TTCCGCCATC. (5) Homozygous or heterozygous for an allele in which the base at the position corresponding to position 824 of SEQ ID NO:2 is A. In the table, "-" indicates that the individual does not have the corresponding genetic characteristic, "+" indicates that the individual has the corresponding genetic characteristic in heterozygosity, and "++" indicates that the individual has the corresponding genetic characteristic in homozygosity. Welch's t-test (two-tailed) was used to evaluate whether there was a statistically significant difference in the content of each steviol glycoside between a population of lines with any one of the genetic characteristics (1) to (5) (mut) and a population of lines with none of the genetic characteristics (1) to (5) (WT). The former had significantly higher RebD, RebE, RebN, and ST contents, and significantly lower RebA and RebG contents than the latter (Table 5). In the table, the values ​​indicate the mean values, "+" indicates a higher content in mut than in WT at P<0.05 and "++" indicates a higher content in mut than in WT at P<0.01, "-" indicates a lower content in mut than in WT at P<0.05 and "--" indicates a lower content in mut than in WT at P<0.01, and "±" indicates no significant difference between the contents of both populations at the significance level of 0.05. The present inventors' analysis revealed that stevia plants have four types of UGT76G1 gene family on the same chromosome (Figure 4). Of these four types, the base sequences of the CDSs of UGT76G1-1, UGT76G1-2, and UGT76G1-4 are shown in SEQ ID NOs: 3, 1, and 2, and the amino acid sequences are shown in SEQ ID NOs: 34, 32, and 33, respectively. It was also revealed that mutations (1) to (3) are located in the coding region of UGT76G1-2, and mutations (4) to (5) are located in the coding region of UGT76G1-4, respectively, and that mutations (1) to (4) cause frameshift mutations and mutation (5) causes a nonsense mutation. The amino acid sequences of the mutant proteins caused by mutations (1) to (5) are shown in SEQ ID NOs: 36, 38, 40, 50, and 52, respectively. These findings suggest that mutations in the UGT76G1 protein family are involved in the composition of steviol glycosides. To examine whether the above mutations affect the expression of the UGT76G1 gene family, RNA was extracted from the sampled fresh leaves and RNA-Seq was performed using a sequencer (HiSeq 2500, Illumina) to obtain the expression levels (FPKM values) of each family gene. The results are shown below (Table 6). We used Welch's t-test (two-tailed) to evaluate whether there was a statistically significant difference in the expression levels of each UGT76G1 family gene between mut and WT, and the expression levels of UGT76G1-1 and UGT76G1-4 were significantly lower in the former than in the latter (Table 7). In the table, the values ​​are the average values, "--" indicates that the expression level of mut is lower than that of WT at P<0.01, and "±" indicates that no significant difference was observed in the expression levels of both populations at the significance level of 0.05. [Example 2] Identification of mutations associated with high RebE phenotype The steviol glycoside content of 126 stevia lines cultivated at the Suntory World Research Center was measured in the same manner as in Example 1. The steviol glycoside content of each line is shown below (Tables 8 to 9). Among the above lines, individuals with characteristic component amounts and good growth were selected, and genome sequencing was performed in the same manner as in Example 1. As a result, for lines with high RebD content, a genetic characteristic of homozygosity for an allele in which the base at the position corresponding to position 609 of SEQ ID NO: 3 is A (genetic characteristic (6')) was found. On the other hand, a line having a genetic characteristic of heterozygosity for an allele in which the base at the position corresponding to position 609 of SEQ ID NO: 3 is T (genetic characteristic (6)) had a significantly higher RebE content than a line having genetic characteristic (6') (Tables 10-11). The present inventors' analysis revealed that mutation (6) is located in the coding region of UGT76G1-1 and causes a nonsense mutation. The amino acid sequence of the mutant protein caused by mutation (6) is shown in SEQ ID NO: 56. Welch's t-test (two-tailed) was used to evaluate whether there was a statistically significant difference in the content of each steviol glycoside between the population of lines (P6) with genetic characteristic (6) and the population of lines (P6') with genetic characteristic (6'). The former had significantly higher contents of RebE, ST, and TSG, and significantly lower contents of RebA, RebB, RebC, RebD, RebF, RebG, RebM, and RebN than the latter (Table 12). In the table, the values ​​indicate the mean values, "+" indicates a higher content in P6 than in P6' with P<0.05, "++" indicates a higher content in P6 than in P6' with P<0.01, and "--" indicates a lower content in P6 than in P6' with P<0.01. To examine whether the above mutations affect the expression of the UGT76G1 gene family, RNA-Seq was performed in the same manner as in Example 1 to obtain the expression levels of each family gene. The results are shown below (Tables 13-14). In the tables, the leaf developmental stages are as follows: ・Stage 1&2: Unexpanded leaves ・Stage 3: Leaves in early development ・Stage 4: Expanded leaves These results indicate that the expression level of UGT76G1-1 is high in the line with genetic feature (6') and low in the line with genetic feature (6) at the same leaf development stage. In addition, since RebE is converted to RebD by UGT76G1, it was suggested that UGT76G1-1 has a preference for the conversion of RebE to RebD.

Claims

1. A stevia plant having at least one of the following genetic characteristics (1) to (5): (1) homozygosity or heterozygosity for an allele in which the sequence corresponding to positions 841 to 842 of SEQ ID NO:1 is AAG. (2) homozygosity or heterozygosity for an allele in which the sequence corresponding to positions 953 to 964 of SEQ ID NO:1 is GT. (3) homozygosity or heterozygosity for an allele in which the sequence corresponding to positions 1338 to 1341 of SEQ ID NO:1 is AG. (4) homozygosity or heterozygosity for an allele in which the sequence corresponding to positions 710 to 711 of SEQ ID NO:2 is TTCCGCCATC. (5) homozygosity or heterozygosity for an allele in which the base at the position corresponding to position 824 of SEQ ID NO:2 is A.

2. A stevia plant having the genetic characteristic (6), which is homozygous or heterozygous for an allele in which the base at the position corresponding to position 609 of SEQ ID NO:3 is A.

3. A stevia plant containing 2.9% or more of RebE per unit mass of dried leaves and having a total content of RebE and stevioside per unit mass of dried leaves of 11.2% or more.

4. A method for producing a stevia plant containing at least one steviol glycoside selected from RebD, RebE, RebN and stevioside in a greater amount than a control stevia plant not having the genetic characteristics (1) to (5), comprising a step of crossing the plant according to claim 1 with a second stevia plant.

5. A method for producing a stevia plant containing at least one steviol glycoside selected from RebE, stevioside, and TSG in a greater amount than a control stevia plant not having the genetic characteristic (6), the method comprising a step of crossing the plant according to claim 2 or 3 with a second stevia plant.

6. A dead tissue or cell of a plant according to any one of claims 1 to 3, or a plant produced by the method of claim 4 or 5.

7. A plant according to any one of claims 1 to 3, a plant produced by the method of claim 4 or 5, or an extract of dead tissue or cells according to claim 6.

8. A method for producing an extract containing steviol glycosides, comprising a step of obtaining an extract from a plant body described in any one of claims 1 to 3, a plant body produced by the method of claim 4 or 5, or a dead tissue or dead cell described in claim 6.

9. A method for producing a purified steviol glycoside product, comprising the step of purifying steviol glycoside from the extract described in claim 7.

10. A method for producing a food or beverage, a sweetener composition, a flavoring, or a medicine, comprising the steps of: providing an extract of a plant body according to any one of claims 1 to 3, a plant body produced by the method of claim 4 or 5, an extract of dead tissue or dead cells according to claim 6, or an extract according to claim 7; and adding the extract to a raw material for the food or beverage, a sweetener composition, a flavoring, or a medicine.

11. A food or drink, a sweetener composition, a flavoring, or a pharmaceutical comprising an extract of a plant body according to any one of claims 1 to 3, an extract of a plant body produced by the method of claim 4 or 5, an extract of dead tissue or dead cells according to claim 6, or the extract according to claim 7.

12. A method for screening the Stevia plant according to claim 1, comprising the step of detecting the presence of at least one of the following genetic characteristics (1) to (5) from a test Stevia plant: (1) homozygosity or heterozygosity for an allele in which the sequence corresponding to positions 841 to 842 of SEQ ID NO:1 is AAG. (2) homozygosity or heterozygosity for an allele in which the sequence corresponding to positions 953 to 964 of SEQ ID NO:1 is GT. (3) homozygosity or heterozygosity for an allele in which the sequence corresponding to positions 1338 to 1341 of SEQ ID NO:1 is AG. (4) homozygosity or heterozygosity for an allele in which the sequence corresponding to positions 710 to 711 of SEQ ID NO:2 is TTCCGCCATC. (5) homozygosity or heterozygosity for an allele in which the base at the position corresponding to position 824 of SEQ ID NO:2 is A.

13. A method for screening the stevia plant according to claim 2 or 3, comprising a step of detecting the presence of a genetic characteristic of homozygosity or heterozygosity for an allele in which the base at the position corresponding to position 609 of SEQ ID NO:3 is A from a test stevia plant.

14. A method for producing the plant according to claim 1, comprising the step of introducing the following mutations into the genome of a stevia plant: (a) a nonsense mutation or a frameshift mutation at a position 5' to the position corresponding to position 1341 of SEQ ID NO: 1, and (b) a nonsense mutation or a frameshift mutation at a position 5' to the position corresponding to position 824 of SEQ ID NO:

2.

15. A method for producing the plant according to claim 2 or 3, comprising the step of introducing a nonsense mutation or a frameshift mutation into the genome of the stevia plant at a position 5' to the position corresponding to position 609 of SEQ ID NO:3.

Citation Information

Patent Citations

  • Single Nucleotide Polymorphism (SNP) Markers for Stevia

    US20210207159A1